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The use of steroids has attracted considerable attention in several areas of acute 
medicine, including acute septic shock and cardiopulmonary bypass. There are 
remarkable similarities in the pathophysiology of these two events, and after 
nearly forty years, the use of steroids for both indications remains highly 
controversial. Steroids have proven to be beneficial in only a few specific 
pathologies, bacterial meningitis in children1, meningitis in adults2, severe 
typhoid fever3, late acute respiratory distress syndrome4, Penumocystis carinii 
pneumonia in acquired immunodeficiency syndrome5 and adrenal 
insufficiency.6 
 
Cardiopulmonary bypass (CPB) induces a systemic inflammatory response 
syndrome (SIRS) in patients following cardiac surgery that can lead to major 
organ injury and postoperative morbidity. Initiation of CPB sets in motion an 
extremely complex and multifaceted response involving complement activation 
along with activation of platelets, neutrophils, monocytes and macrophages. 
These changes initiate the coagulation, fibrinolytic and kallikrein cascades, 
increasing blood levels of various endotoxins, cytokines and increasing 
endothelial cell permeability.  
 
The physiological insults caused by CPB have been associated with major 
postoperative morbidity, including neurological, pulmonary and renal 
dysfunction, and/or haematological abnormalities. Additional clinical 
manifestations associated with the SIRS include increased metabolism (fever), 
fluid retention, myocardial oedema and detrimental haemodynamic changes. 
 
The use of steroids began in the mid 1960s, following reports of their beneficial 
effects in septic shock.  In 1974, Weitzman and Berger7 systematically reviewed 
32 original clinical investigations published between 1950 and 1971 that 
addressed the use of corticosteroids in bacterial infections. Of the 12 studies 
involving septic shock, nine advocated the use of corticosteroids and three 
concluded that steroids were not beneficial.  
 
Two years later, Schumer8 published a report that demonstrated very 
impressive reductions in mortality in patients with septic shock treated with 
corticosteroids. Mortality rates of 11.6% and 9.3% were reported for patients 
treated with methylprednisolone (30 mg/kg iv) and dexamethasone (3 mg/kg iv) 
respectively, versus 38.4% for patients receiving placebo. Based on this report, it 
became standard practice in the late 1970s and early 1980s to administer high-
dose corticosteroids at the onset of septic shock. 
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In the 1980s there were several well-designed single centre studies as well as two 
large multicentre clinical trials. In an open label trial, Sprung and colleagues9 
randomized 59 patients to receive methylprednisolone, 30 mg/kg iv, 
dexamethasone 6 mg/kg iv or placebo. Objective criteria for septic shock 
closely approximated current consensus criteria, and outcome measures were 
well established. They demonstrated more rapid shock reversal as well as 
improved survival at 6 days after drug administration with corticosteroids. This 
survival benefit disappeared, however, when patients were followed up beyond 
10 days. In another single centre study, Luce and colleagues10 found no 
improvement in survival or ARDS in a double blind comparison of 
methylprednisolone versus placebo in 75 patients with septic shock.  
 
The results of two large multicentre clinical trials of steroids in sepsis were 
published in 1987. In the Veteran Administration trial,11 233 patients were 
randomized to receive methylprednisolone (30 mg/kg iv) or placebo within 
three hours of diagnosis. No difference in 14-day mortality or complications was 
demonstrated. In the largest clinical trial, Bone and colleagues12 randomized 
381 patients to receive methylprednisolone (30 mg/kg iv) or placebo. Patients 
who received methylprednisolone had a higher mortality rate than those in the 
placebo group. As a result of these multicentre trials, the use of corticosteroids 
for septic shock fell out of favour. Reviews and critical care textbooks in the 
1990s have generally cautioned against the use of supraphysiological doses of 
corticosteroids in septic shock. 
 
In 2003, critical care and infectious disease experts representing 11 international 
organizations developed management guidelines for the use of corticosteroid 
therapy in patients with sepsis and septic shock that would be of practical use 
for the bedside clinician.13 Among their recommendations it is clearly stated 
that the use of corticosteroids in high doses is strongly discouraged.   
 
Interestingly, the use of steroids in cardiac surgery developed in a similar 
pattern to that in sepsis. Following animal studies carried out in the 1960s, 
methylprednisolone became the drug of choice because of its anti-inflammatory 
potency and minimal tendency to induce sodium and water retention. An 
intravenous dose of 30 mg/kg was at that time considered optimal because this 
had been shown to be beneficial in clinical shock studies,14 yet caused no 




A seminal study published in 1970 by Dietzmanand and colleagues16 reported 
that methylprednisolone (30 mg/kg) was effective in treating the low output 
syndrome in dogs and humans following cardiac surgery. Specifically, in 98 
dogs, methylprednisolone administration decreased systemic vascular resistance, 
increased cardiac index, improved tissue perfusion, and increased survival from 
22 to 65%. In 19 humans following cardiac valve replacement the same 
beneficial haemodynamic effects were observed. 
 
In the early 1980s the pivotal role that complement activation played in the 
basic physiological insults caused by CPB was demonstrated. This triggered a 
number of investigations focusing on the effect of steroids on post-bypass 
complement activation and cytokines production. An overwhelming number of 
these studies demonstrated that the use of steroids was associated with a 
considerable reduction of proinflammatory cytokines production in the 
postoperative period.  
 
However we had to wait another decade to see investigators moving away from 
biochemical parameters and focusing on clinical outcome. Tassani and 
colleagues17 showed in 1999 that patients given methylprednisolone had better 
haemodynamic parameters in the postoperative period although extubation 
time was not affected. More recently Yared and colleagues18 reported, in a 
study involving more than 200 patients, that giving dexamethasone before CPB 
started was associated with earlier tracheal extubation than the placebo group. 
In contrast to these two previous studies Chaney and colleagues19,20 
demonstrated in two prospective randomized trials that the use of 
methylprednisolone was associated with delayed tracheal extubation and was 
not associated with any haemodynamic improvements.  
 
In paediatric cardiac surgery the use of steroids has not been investigated to the 
same extent as in adults, and its use is as controversial. Lindberg and 
colleagues21 considered that it was unethical not to use dexamethasone in 
children weighing less than 10 kg scheduled for cardiac surgery. Schroeder and 
colleagues22 accept that the lack of a control group without methylprednisolone 
is a limiting factor in their study. According to them it is standard practice to 
use steroids in these patients. Dexamethasone appears to reduce postoperative 
troponin I production.23 It has also been shown to reduce the production of C-
reactive protein without any effect on the release of protein S100B and Von 
Willebrand factor.21 The concentration of proinflammatory cytokines decreases 
when steroids are used before CPB starts.24 The reduction is even more 
remarkable if steroids are given before and during CPB.22  
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Oxygen delivery and cardiac output improve faster when steroids were used in 
an animal model.25 Even the timing of the administration seems to be 
relevant.26 However, when clinical end points have been used to test the 
benefits of steroids the results are not so impressive.27  
 
Our aim in this thesis was to investigate how dexamethasone could influence 
the side effects associated with CPB in two organs, the small intestine and the 
heart. To that purpose we chose two surrogate markers, gut permeability and 
cardiac troponin T production.  
 
The dual sugar permeability test to assess gut permeability was introduced in 
the 1970s to overcome the problems associated with the use of single markers. 
After thirty years it has stood the test of time and remains in use for clinical and 
research purposes. Gut permeability had not been investigated in paediatric 
patients undergoing cardiac surgery. Before examining the effect of 
dexamethasone on gut permeability we first had to evaluate the changes in 
intestinal permeability during the perioperative period in patients undergoing 
surgery with and without cardiopulmonary bypass. This study is presented in 
chapter two. 
 
Proinflammatory cytokines have a deleterious effect on the intestinal barrier 
when studied in vitro.28 In the same in vitro model, when the intestinal mucosa 
is exposed to anti-inflammatory cytokines, the gap between the epithelial cells of 
the intestinal mucosa improves.29 Animal studies have shown that steroids 
accelerate the maturation and stimulate the growth of the intestinal mucosa in 
ex-premature animals and it has long been accepted that steroids given to the 
pregnant mother reduce the risk of necrotizing enterocolitis  in the premature 
baby. 
 
Chapter three describes the effect of dexamethasone on gut permeability when 
administered during induction of anaesthesia in paediatric patients undergoing 
cardiac surgery with cardiopulmonary bypass. The results of this study confirm 
what has been already shown in in vitro studies; although the mechanism is not 
clear, dexamethasone reduces gut permeability when given before CPB starts. 
 
Neonates with a hypoplastic left heart syndrome undergoing stage I of the 
Norwood operation are at higher risk of intestinal ischaemia in the perioperative 
period. In these patients the systemic and pulmonary circulations depend on 
one functioning ventricle.  
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This can expose the patient to periods when there is an imbalance between the 
systemic and pulmonary circulations, with excessive pulmonary flow to the 
detriment of mesenteric perfusion. The surgical procedure requires a period of 
circulatory arrest, adding an extra insult to the mesenteric circulation. 
Necrotizing enterocolitis is relatively uncommon in paediatric patients 
undergoing cardiac surgery, however mortality is nearly 100% in patients with 
HLHS.30 It has been common practice in our institution to use steroids in these 
occasions only. We felt that preoperative and intraoperative insults to the 
intestinal mucosa in this group of patients warranted a separate investigation. 
The results are presented in chapter four. 
 
Sometimes research produces totally unexpected results. Rhamnose is one of 
the saccharides used in the dual sugar permeability test. For the last thirty years 
it has been assumed that rhamnose was an inert sugar, which did not undergo 
any metabolism in humans. However we found increased concentrations of 
rhamnitol, a metabolite of rhamnose, in the urine of patients undergoing the 
DSPT. This is evidence that rhamnose is indeed metabolized by the human 
body and the results are presented in chapter five. 
 
Cardiac troponin T (cTnT) is a specific marker of myocardial infarction.31 It is 
also a reliable marker of myocardial injury in the paediatric population.32 
Before we investigated the effect of dexamethasone on postoperative release of 
cTnT another issue had to be addressed. 
 
The anaesthetic agent used during the surgical procedure could influence cTnT 
concentrations postoperatively. Several studies have demonstrated that 
sevoflurane and other volatile anaesthetics reduce the postoperative production 
of cardiac troponin I when compared to other anaesthetic agents in adult 
patients undergoing coronary graft surgery.33,34 
 
The theoretical explanation for this benefit can be found in the process of 
anaesthetic preconditioning. Exposing the adult myocardium to brief periods of 
ischaemia and reperfusion induces greater tolerance to a subsequent, more 
prolonged ischaemic insult, a phenomenon known as ischaemic 
preconditioning (IP). Animal experiments have shown that inhalational 
anaesthetics, morphine, and possibly other opioids mimic the effects of 
ischaemic preconditioning. This is often referred to as anaesthetic 
preconditioning. The results of our study and further discussion over the subject 
are presented in chapter six. 
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A possible consequence of the SIRS related to the use of CPB is myocardial 
damage. This can manifest itself as a low output syndrome with a need for high 
inotropic support in the postoperative period. cTnT concentrations rise up to 
three fold postoperatively in children undergoing cardiac surgery when 
compared to adults undergoing coronary bypass surgery.35 
 
Human and animal studies have shown a reduction in cardiac troponin I 
concentrations after CPB related to the use of steroids.36,37 The explanation for 
this is not totally clear. The use of cardiac troponin I in paediatric cardiac 
surgery is limited by the fact that for up to two years after birth in infants with 
congenital heart disease and for up to nine months after birth in healthy infants, 
troponin I is produced not only by myocardial muscle but also by skeletal 
muscle. Slow twitch skeletal muscle troponin I is expressed in variable amounts 
in these infants.38 
 
When cTnT was used as an end point to test the effect of dexamethasone on 
myocardial protection, patients receiving dexamethasone before CPB had lower 
concentrations of cTnT in the postoperative period. However, these changes 
were short-lived and 24 h after admission to the intensive care unit there were 
no differences between the two groups. The subject is further discussed in 
chapter seven. In the same study we have shown that dexamethasone did not 
improve morbidity. Sixty-eight patients were needed to demonstrate a 50% 
reduction in the postoperative use of inotropic support or an 18 hours reduction 
in ventilator hours. However, the use of dexamethasone was not associated with 
any changes in postoperative ventilator hours or the amount of inotropic 
support needed in the postoperative period. 
 
As one could expect this thesis provides no definitive answer to the use of 
dexamethasone (1 mg kg-1) before CPB starts. On the one hand dexamethasone 
does not seem to provide any benefits in terms of lowering postoperative 
morbidity. On the other hand it does clearly reduce gut permeability in the 
postoperative period. Since intestinal complications in this group of patients are 
relatively rare, a sufficiently powered study to test the benefits of 
dexamethasone using intestinal complications as an end point would be 
difficult, if not impossible. However, mortality related to intestinal complications 
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Background: Intestinal mucosal ischaemia can occur in infants and children 
during and after cardiac surgery. Severe decreases in mucosal perfusion may be 
a causative factor for postoperative mortality or complications such as 
necrotizing enterocolitis. We have investigated gut permeability in paediatric 
patients undergoing cardiac surgery using the dual sugar permeability test and 
absorption of two other saccharides. 
 
Methods: Thirty-four patients undergoing palliative or corrective surgical 
procedures with and without cardiopulmonary bypass were investigated. 
Intestinal permeability was measured using 3-O-methyl-D-glucose, D-xylose, L-
rhamnose and lactulose, given orally after induction of anaesthesia and 12 and 
24 hours later. 
 
Results: Lactulose/Rhamnose ratios were increased from the outset, 0.39 (0.07-
1.8) (median CI) for patients undergoing operations without cardiopulmonary 
bypass and 0.30 (0.02-2.6) with cardiopulmonary bypass. The highest 
Lactulose/Rhamnose ratios were recorded 12 hours after surgery 0.32 (0.07-6.9), 
when cardiopulmonary bypass was used. This is approximately seven times the 
value expected in healthy children. There was an improvement in patients not 
undergoing cardiopulmonary bypass: 0.22 (0.03-0.85) 12 hours and 0.11 (0-0.48) 
24 hours after induction of anaesthesia. Patients undergoing repair of aortic 
coarctation showed the fastest recovery: 0.09 (0.03-0.31) 12 hours and 0.07 (0.04-
0.35) 24 hours after induction of anaesthesia.  
 
Conclusions: Patients with congenital heart defects have abnormal gut 
permeability when compared to healthy children of similar age. 
Cardiopulmonary bypass seems to affect the intestinal barrier morphologically 
(lactulose and rhamnose absorption) and functionally (3-O-methyl-D-glucose 












Intestinal mucosal ischaemia, although transient, can occur in infants and 
children during and after cardiopulmonary bypass (CPB).1 Severe decreases in 
mucosal perfusion may be a causative factor for postoperative mortality or 
complications such as necrotizing enterocolitis (NEC). NEC can have 
devastating consequences, e.g. in patients undergoing repair of hypoplastic left 
heart syndrome2 (mortality more than 90%). Neonates with aortic arch 
anomalies and infants subjected to CPB-induced profound hypothermia may be 
at particular risk of developing splanchnic ischaemia in the perioperative 
period.3 These studies used indirect indicators of intestinal mucosal perfusion 
(e.g. laser Doppler probe or gastric tonometry). Patients with coarctation of the 
aorta may, on the other hand, be exposed to reperfusion injuries after the 
surgical repair, manifesting as the postcoarctectomy syndrome.4  
 
Intestinal permeability can be evaluated noninvasively by measuring the urinary 
excretion of orally administered water-soluble, non-degradable test molecules.5,6 
This barrier function test is based on the comparison of intestinal permeation of 
larger molecules with that of smaller molecules by measuring the ratio of their 
urinary excretion. These two types of molecules follow different routes of 
intestinal permeation: the larger molecules are assumed to permeate 
paracellularly, and the smaller molecules transcellularly.  
 
Preabsorption factors such as gastric emptying, dilution by secretion and 
intestinal transit time, and post-absorption factors such as systemic distribution 
and renal clearance are assumed to affect both molecules equally. Four 
saccharides, 3-O-methyl-D-glucose (molecular weight 194 Da), D-xylose 
(molecular weight 150 Da), L-rhamnose (R, molecular weight 164 Da) and 
lactulose (L, molecular weight 342 Da) are employed to assess active carrier-
mediated, passive carrier-mediated, transcellular, and paracellular transport, 
respectively in the small intestine.  
 
Intestinal permeability is considered to be normal if the lactulose (% 
recovery)/rhamnose (% recovery) (L/R) ratio is below 0.05.5 Intestinal absorptive 
capacity for saccharides is considered to be normal when the recoveries of D-
xylose (passive carrier-mediated transport) and 3-O-methyl-D-glucose (active 
carrier–mediated transport) are around 10% and 30% respectively.7  
 
The aim of our study was to observe the changes in gut permeability in 
paediatric patients undergoing cardiac surgery using the dual sugar 
permeability test (DSPT). 
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Materials and methods 
 
After approval from the local ethics committee and informed consent from the 
parents or legal guardians, 34 patients were enrolled in this prospective, non-
randomized observational study. Patients received a premedication consisting 
on oral atropine (0.02 mg kg-1) and midazolam (0.5 mg kg-1) 30 min before 
induction of anaesthesia. Anaesthesia was induced with sevoflurane followed by 
a bolus of sufentanil (1 µg kg-1) and pancuronium (0.2 mg kg-1). Maintenance of 
anaesthesia consisted on a combined continuous infusion of midazolam (0.2 mg 
kg-1 h-1) and sufentanil (2 µg kg-1 h-1). The lungs of the patients were 
mechanically ventilated with a mixture of oxygen and air. Mechanical 
ventilation was maintained until cardiopulmonary bypass (CPB) commenced. 
After heparin administration (3 mg kg-1) and aorta cannulation, CPB was 
instituted with a Dideco hollow fibre oxygenator with a blood flow between 200 
and 300 ml kg-1 min-1. The prime volume, between 325 and 750 ml according 
to the patientÊs weight, contained lactate-free RingerÊs solution, albumin, 
mannitol, blood and heparin. Patients underwent modified ultra-filtration at the 
end of the surgical procedure. The effect of heparin was reversed with 
protamine sulphate at a ratio of 1 mg protamine for 1 mg heparin.  
 
After induction of anaesthesia, 2 ml kg-1 of the sugar solution was administered 
through a nasogastric tube. Urine was subsequently completely collected 
through a urinary catheter for 3 h, the total volume was recorded and samples 
were stored at -20° C until analysis. This process was repeated 12 and 24 h after 
induction of anaesthesia.  
 
The sugar solution, prepared by the hospital pharmacy, contained 3-O-methyl-
D-glucose (2 g litre-1), D-xylose (5 g litre-1), L-rhamnose (10 g litre-1) and 
lactulose (50 g litre-1). The osmolarity of the solution is approximately 240 
mOsm l-1.  
 
Sugar concentrations in urine were determined by gas chromatography 
following a slight modification8 of the procedure described by Jansen and 
colleagues.9 Briefly, to an aliquot of urine corresponding to 0.5 µmol of 
creatinine 30 µg of ribitol and 10µg of trehalose (Sigma-Aldrich, St. Louis, USA) 
were added as internal standards (ribitol for the determination of 3-O-methyl-D-
glucose, D-xylose and L-rhamnose and trehalose for lactulose) for the 
determination of 3-O-methyl-D-glucose, D-xylose, L-rhamnose and lactulose.  
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The sample was dried, derivatized with 300µl Tri-Sil TBT (Pierce, Rockford, 
USA) at 100° C and partly hydrolyzed with water. Subsequently the intact sugar 
trimethylsilyl (TMS) derivatives were extracted with hexane and after 
concentrating, gas chromatographic analysis was performed on a 30 m capillary 
fused silica HP-1 column (Agilent, Palo Alto, USA) using split injection. 
Quantification was performed after the construction of standard addition 
calibration curves.The type of vasoactive drugs and their amount were recorded 
after admission to the intensive care unit and 24 h later. To quantify inotropic 
support, inotrope scores were calculated as the sum of all inotrope doses 
correcting for potency (dopamine, dobutamine =1, milrinone = 15, epinephrine 
= 100).10,11 Fluid intake (including crystalloids, colloids and blood products), 
output (urine, blood and serous fluid loss) and balance were recorded over a 36 




 Data were analysed with the statistical package SPSS 10. Data are presented as 
median (95% confidence intervals). The data were not normally distributed and 
we used Mann-Whitney U-test for unpaired data and the Friedman test for 
sequential data. Values of P < 0.05 were considered significant. Based on a 
previous study6 that found a mean (SD) L/R ratio of 0.047 (0.018), a prospective 
analysis showed that we needed a sample size of 34 to detect a difference in the 
L/R ratio of 0.02, with α = 0.05 and a power of 80%.  
 
 
                                            No CPB                     CPB        P value 
 
Number of patients           17   17             
Age (months)              2 (0.2-24)  5 (2-47)  0.17 
Sex (M/F)                          8/9         6/11   0.72 
Weight (kg)        4.8 (2.5-15)  6 (4-14)  0.24 
Surgery time (min)     83 (45-160)  73 (176-360)  0.01  
Bypass time (min)          0   105 (73-202)          
Aortic clamp time (min)   0 (0-21)  73 (0-150) 
Ventilator hours        24 (6-144)  48 (24-168)  0.11 
 






Table 1 shows patients characteristics. The groups were comparable with 
respect to age, sex and weight. The type of operations performed in each group 
is shown in table 2. Table 3 shows the L/R ratios and percentage recovery of the 
four sugars throughout the study period. Figure 1 is a graphic representation of 
the L/R changes in both groups. Patients undergoing repair of aortic coarctation 
showed the fastest improvement in L/R ratios 0.52 (0.21-1.01) at T0, 0.09 (0.03-
0.31) at T12 and 0.07 (0.04-0.35) at T24 (P < 0.01). Those patients receiving a 
Blalock-Taussig shunt or banding of the pulmonary artery had the following L/R 
ratios: 0.37 (0.06-1.81) at T0, 0.27 (0.12-0.85) at T12 and 0.14 (0-0.48) at T24 (P< 
0.04). Inotropic scores (median  95% confidence intervals) on admission to the 
ICU 5 (0-59.7) were not significantly different from those at 24 h after admission 
5 (0-54) in the CPB group. In the group without CPB inotropic scores were 0 (0-
10) after admission and 0 (0-15) at 24 h. 
 
No CPB      CPB 
 
Coarctation of the aorta  7   Aortic stenosis  1 
Banding pulmonary artery 3   AVSD   2 
Blalock-Taussig shunt  7   Glenn   2 
MVA    2 
TAPVC   2 
ToF    1 
VSD    7 
Total     17      17 
 
Table 2: Type of operations performed in each group. Atrioventricular septal defect (AVSD). 
Mitral valve anuloplasty (MVA). Total anomalous pulmonary venous connection (TAPVC). 
Tetralogy of Fallot (ToF). Ventricular septal defect (VSD). 
 
 
Patients operated without CPB had a fluid intake of 79 ml kg-1 (39-251) and 
output of 70 ml kg-1 (22-176), with an overall fluid balance of 18 ml kg-1 (-97 - 
92). For those patients undergoing operations with CPB the fluid intake was 86 
ml kg-1 (41 - 147) and output 58 ml kg-1 (23 - 110) with an overall balance of 31 





                                         T0                          T12               T24 
 
L/R  No CPB 0.39 (0.07-1.8) 0.22 (0.03-0.85) 0.11 (0-0.48)  
CPB          0.30 (0.02-2.6) 0.32 (0.07-6.9) 0.24 (0.05-3.2)* 
 
Lactulose No CPB 0.18 (0.02-0.73) 0.35 (0.01-1.2) 0.41 (0.2-0.92)† 
CPB  0.03 (0.01-0.3)* 0.29 (0.07-1.76)    0.82 (0.05-3.32) † 
 
Rhamnose No CPB 0.29 (0.04-1.56) 1.56 (0.12-11.1) 3.64 (1.2-17.6) † 
CPB        0.08 (0.03-1.14)* 1.17 (0.06-4.23) 3.8 (0.04-18.1) † 
  
3OMG No CPB 0.64 (0.11-9.21) 3.9 (0.11-25.34) 14.1 (2.2-55.3) † 
CPB         0.19 (0.04-1.88)* 1.31 (0.1-12.93) 7.4 (0.03-48.6)† 
 
Xylose No CPB 0.72 (0.17-2.89) 1.34 (0.27-14.81)   3.3 (0.92-38.31) † 
  CPB  0.2 (0.04-1)*  0.73 (0.07-7.3)      2.1 (0.04-18.14) † 
 
Table 3: Lactulose/rhamnose ratios (L/R) and percentage recovery for lactulose, rhamnose, 3-
O-methyl-glucose (3OMG) and xylose without and with cardiopulmonary bypass (CPB). 
Values are expressed as median (95% confidence intervals). * Denotes statistical significance 














         *        †
 
Fig 1: Changes in L/R ratios in both groups at induction of anaesthesia (T0), 12 hours (T12) 
and 24 hours (T24) after induction of anaesthesia. Values are expressed as median, 25th – 
75th  interquartile ranges (bars) and 2.5th and 97.5th percentile (error bars). * Denotes 




To our knowledge this is the first report in the literature of changes in gut 
permeability in paediatric patients with congenital heart defects undergoing 
cardiac surgery. Our study shows that from the outset L/R ratios were well 
above the normal values expected in patients of similar age without cardiac 
defects.  
 
Only patients undergoing repair of coarctation of the aorta had near normal 
L/R ratios 24 h after the surgical procedure. The DSPT has been used to assess 
intestinal function in healthy neonates, in whom the L/R ratios were around 
0.05.5 Paediatric patients without intestinal pathology have a similar ratio; range 
0.023 – 0.074 and mean (SD) 0.047 (0.018).6 Several studies have investigated 
the effect of cardiopulmonary bypass on intestinal permeability in the adult 
population.12-14 In all of them the investigators demonstrated an increase in gut 
permeability that reverted to normal during the postoperative period.  
In animals, exposure to CPB induces a transient mesenteric endothelial 
dysfunction with an increased contractile response to an α1-adrenergic 
agonist.15 
 
Cyanotic patients may be at higher risk of developing intestinal mucosal 
ischaemia. This may also be true for patients with coarctation of the aorta 
because of a reduced blood flow through the descending aorta. Infants 
undergoing cardiac surgery often have chronic low arterial oxygen 
concentrations due to intra- or extra-cardiac shunting.  Neonates with 
hypoplastic left heart syndrome have at times preferential blood flow to the 
pulmonary circulation at the expense of the systemic circulation. Those patients 
operated without CPB had either a total correction of their disease (coarctation 
of the aorta) or an improvement in the systemic oxygen delivery via a Blalock-
Taussig shunt or a pulmonary banding. It is therefore logical in these patients to 
expect an improvement in the L/R ratios and recovery of single markers.  
 
The accuracy of the DSPT relies on the complete collection of urine samples 
during the study period. This is a limiting factor on the applicability of the test 
in non-cooperative patients without a urinary catheter. A high percentage of 
patients are discharged to the ward the day after surgery with the consequent 
removal of urinary catheters. For this reason we performed the test during the 
first 24 hours after the operation.  
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There has been criticism concerning the interpretation and significance of the 
DSPT in the literature.16,17 In an animal model it was shown that fluid loading 
increased the L/R ratios independent of changes in intestinal permeability. Rats 
received in an 8-hour period a fluid bolus equivalent to twice the daily fluid oral 
intake. Put into perspective, this means an infant of 10 kg would receive in an 8-
hour period approximately 2 litres fluid intravenously. We carefully 
documented the fluid balance during the study period. On average patients 
received less than the daily maintenance fluid expected for their age. 
 
When lactulose and rhamnose are combined in the test solution at a fixed 
concentration ratio, the effect of preabsorption factors (gastric emptying, 
dilution by secretions, intestinal transient time) and postabsorption factors 
(systemic distribution and renal clearance) will apply equally to both. Therefore 
the L/R ratio is only influenced by the difference in gut permeability for each 
molecule.18 Pre and postabsorption factors may influence single markers such 
as D-xylose and 3-O-methyl-D-glucose. D-xylose is absorbed through a passive 
carrier-mediated transport and 3-O-methyl-D-glucose through an active carrier-
mediated transport. These two single markers provide information about the 
functional state of the intestinal mucosa while the L/R ratio is a reflection of the 
mucosal integrity at the morphological level. Results of recovery of single 
markers should be always interpreted in conjunction with L/R ratios. 
 
From the outset patients operated without CPB had better percentage recovery 
for both single markers although the differences were significant after induction 
of anaesthesia only. However the L/R ratio is worse in this group than in the 
one requiring CPB in the same period. It is difficult to draw conclusions at this 
point in time. Nevertheless the trend is towards a faster improvement of single 
markers in the group without CPB keeping in mind, that 24 h after the 
operation the values are far from normal. 
 
We assume that the deterioration or lack of improvement in the L/R ratios 12 h 
after induction of anaesthesia must be related to the use of CPB. Interestingly 
CPB did not prevent a progressive and significant increase in the percentage 
recovery of D-xylose and 3-O-methyl-D-glucose. It appears that CPB damages 
temporarily the intestinal mucosa at the morphological level. At the functional 
level though, CPB may only delay a process that begins with the surgical 




Inotropic support was necessary more often in the group undergoing CPB. It 
may be argued that this factor alone can explain the differences in L/R ratios 
between the two groups. However, inotropic support in the CPB group did not 
change between admission to intensive care and twenty-four hours later, while 
the L/R ratios did improve, although not significantly. 
 
Used on a regular basis the DSPT may help us to identify the optimal time to 
reintroduce enteral feeding in the postoperative period. This indeed deserves 
further research. Novel surgical techniques or drugs aimed at protecting the 
splanchnic circulation can be tested against the DSPT as an end point. We are 
at present studying how the use of dexamethasone before CPB starts affects gut 
permeability in the postoperative period during paediatric cardiac surgery.   
 
In conclusion, we have shown that paediatric patients undergoing cardiac 
surgery with CPB have median L/R ratios up to seven times the normal values 
expected in healthy children. Patients undergoing surgical repair of aortic 
coarctation show a swift return to near normal values twenty-four hours after the 
operation. From our results we can also conclude that the intestinal barrier is 
affected both at the morphological and functional levels. Measurement of 
mesenteric blood and oxygen supply in the paediatric population remains a 
difficult task. Only by using non-invasive, non-toxic surrogate markers of 
intestinal perfusion can we investigate and most importantly try to improve 
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Objectives: Little attention has been paid to the effect of the systemic 
inflammatory response syndrome on intestinal dysfunction in the postoperative 
period. Several proinflammatory cytokines have been reported to increase the 
permeability of intestinal mucosa in vitro. We investigated the effect of 
dexamethasone on gut permeability in paediatric patients undergoing cardiac 
surgery using the dual sugar permeability test and absorption of two other 
saccharides. 
 
Methods: Thirty-four patients scheduled for cardiac surgery with 
cardiopulmonary bypass were prospectively randomized to either act as 
controls or receive dexamethasone (1 mg kg-1) during induction of anaesthesia. 
Intestinal permeability was measured using 3-O-methyl-D-glucose, D-xylose, L-
rhamnose and lactulose, given orally after induction of anaesthesia and 12 and 
24 hours later. 
 
Results: Lactulose/rhamnose ratios were elevated from the outset in both 
groups; (mean (95% Confidence intervals)) 0.57 (0.24 – 0.91) for the control 
group and 0.76 (0.35 – 1.17) for patients receiving dexamethasone. While the 
ratios decreased 12 h (0.29 (0.17 – 0.42)) and 24 h later (0.17 (0.08 – 0.15)) in 
the dexamethasone group, in the control group there was a rise at 12 h (0.77 (0 
– 1.64)), with a slight reduction 24 h later (0.46 (0.06 – 0.85)).  
 
Conclusions: Infants and children undergoing cardiac surgery with 
cardiopulmonary bypass show a significant reduction in gut permeability when 
dexamethasone is used during induction of anaesthesia. Dexamethasone does 
not affect the intestinal barrier at the functional level as assessed by (3-O-methyl-















Cardiopulmonary bypass (CPB) can trigger a systemic inflammatory response 
syndrome. This may result postoperatively in fever, fluid retention and 
pulmonary, renal, cardiac and cerebral dysfunction.1 Little attention has been 
paid to the effect of CPB and the associated systemic inflammatory response on 
intestinal dysfunction in the postoperative period.  
 
The postoperative release of inflammatory mediators after paediatric cardiac 
surgery has been reviewed extensively elsewhere.2 Several proinflammatory 
cytokines have been reported to increase the permeability of intestinal mucosa 
in vitro.3 Antiinflammatory cytokines on the other hand ameliorated induced 
gut epithelial hyperpermeability in vitro.4 The mechanisms involved in this 
phenomenon are not totally clear.  
 
Intestinal permeability can be evaluated noninvasively by measuring the urinary 
excretion of orally administered water-soluble, non-degradable test molecules.5,6 
This barrier function test is based on the comparison of intestinal permeation of 
larger molecules with that of smaller molecules by measuring the ratio of their 
urinary excretion. These two types of molecules follow different routes of 
intestinal permeation: the larger molecules are assumed to permeate 
paracellularly, and the smaller molecules transcellularly. Preabsorption factors 
such as gastric emptying, dilution by secretion and intestinal transit time, and 
post-absorption factors such as systemic distribution and renal clearance are 
assumed to affect both molecules equally. Four saccharides, 3-O-methyl-D-
glucose (molecular weight 194 Da), D-xylose (molecular weight 150 Da), L-
rhamnose (R, molecular weight 164 Da) and lactulose (L, molecular weight 342 
Da) are employed to assess active carrier-mediated, passive carrier-mediated, 
transcellular, and paracellular transport, respectively in the small intestine. 
Intestinal permeability is considered to be normal if the lactulose (% 
recovery)/rhamnose (% recovery) (L/R) ratio is below 0.05.5 Intestinal absorptive 
capacity for saccharides is considered to be normal when the minimum 
recoveries of D-xylose (passive carrier-mediated transport) and 3-O-methyl-D-
glucose (active carrier–mediated transport) are around 10% and 30% 
respectively.7 A previous study has shown that preoperative L/R ratios in 
patients with congenital heart defects are on average up to eight times higher 
than in healthy neonates.8  
 
The possible clinical applications of the dual sugar permeability test (DSPT) 
have not been explored in this group of patients. Gastrointestinal complications 
in the postoperative period are rare, but with devastating consequences, such as 
necrotizing enterocolitis in patients with the hypoplastic left heart syndrome.9 
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The DSPT may be used as a surrogate marker to test the effect of drugs or 
novel therapies on the splanchnic circulation. The use of steroids in cardiac 
surgery remains controversial.10 There is evidence in the literature that steroids, 
given before the start of CPB, reduce the release of proinflammatory mediators 
associated with both adult and paediatric cardiac surgery.11,12 However the 
benefits of steroids on clinical outcome are not totally proven.13 
 
The aim of our study was to observe the effect of a single dose of 
dexamethasone before CPB starts on the changes in gut permeability in 
paediatric cardiac surgery using the DSPT. 
 
Materials and methods 
 
After approval from the local ethics committee and informed consent from the 
parents or legal guardians, 34 patients were enrolled in this prospective, 
randomized, single blinded interventional study. Patients were allocated to 
receive either dexamethasone (1 mg kg-1 during induction of anaesthesia) or act 
as controls. The use of placebo is not allowed by our local ethics committee. 
Patients received a premedication consisting on oral atropine (0.02 mg kg-1) and 
midazolam (0.5 mg kg-1) 30 min before induction of anaesthesia. Anaesthesia 
was induced with sevoflurane followed by a bolus of sufentanil (1 µg kg-1) and 
pancuronium (0.2 mg kg-1). Maintenance of anaesthesia consisted on a 
combined continuous infusion of midazolam (0.2 mg kg-1 h-1) and sufentanil (2 
µg kg-1 h-1). The lungs of the patients were mechanically ventilated with a 
mixture of oxygen and air. Mechanical ventilation was maintained until CPB 
commenced. After heparin administration (3 mg kg-1) and aorta cannulation, 
CPB was instituted with a Dideco hollow fibre oxygenator with a blood flow 
between 200 and 300 ml kg-1 min-1.  
 
The prime volume, between 325 and 750 ml according to the patientÊs weight, 
contained lactate-free RingerÊs solution, albumin, mannitol, blood and heparin. 
No steroids were added to the prime. Patients underwent modified ultra-
filtration at the end of the surgical procedure. The effect of heparin was 
reversed with protamine sulphate in a ratio of 1 mg protamine for 1 mg 
heparin. After induction of anaesthesia, 2 ml kg-1 of the sugar solution was 
administered through a nasogastric tube. Urine was subsequently completely 
collected through a urinary catheter for 3 h, the total volume was recorded and 
samples were stored at -20° C until analysis. This process was repeated 12 and 
24 h after induction of anaesthesia.  
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The sugar solution, prepared by the hospital pharmacy, contained 3-O-methyl-
D-glucose (2 g litre-1), D-xylose (5 g litre-1), L-rhamnose (10 g litre-1) and 
lactulose (50 g litre-1). The osmolarity of the solution is approximately 240 
mOsm l-1.  
 
Sugar concentrations in urine were determined by gas chromatography 
following a slight modification14 of the procedure described by Jansen and 
colleagues.15 Briefly, to an aliquot of urine corresponding to 0.5 µmol of 
creatinine 30 µg of ribitol and 10µg of trehalose (Sigma-Aldrich, St. Louis, USA) 
were added as internal standards (ribitol for the determination of 3-O-methyl-D-
glucose, D-xylose and L-rhamnose and trehalose for lactulose). The sample was 
dried, derivatised with 300µl Tri-Sil TBT (Pierce, Rockford, USA) at 100° C 
and partly hydrolyzed with water. Subsequently the intact sugar trimethylsilyl 
(TMS) derivatives were extracted with hexane and after concentrating, gas 
chromatographic analysis was performed on a 30 m capillary fused silica HP-1 
column (Agilent, Palo Alto, USA) using split injection. Quantification was 
performed after the construction of standard addition calibration curves. The 
type of vasoactive drugs and their amount were recorded after admission to the 
intensive care unit and 24 h later. 
  
To quantify inotropic support, inotrope scores were calculated as the sum of all 
inotrope doses correcting for potency (dopamine, dobutamine =1, milrinone = 
15, epinephrine = 100).16 Fluid intake (including crystalloids, colloids and blood 
products), output (urine, blood and serous fluid loss) and balance were 
recorded over a 36 h period following admission to the intensive care unit. Urea 
and creatinine concentrations were measured preoperatively, immediately after 




Data were analyzed with the statistical package SPSS v10. Data are presented as 
mean (95% confidence intervals). Patients characteristics (age, weight, surgery 
times and ventilator hours), fluid balance and inotropic scores were analyzed by 
unpaired t test. Because L/R ratios and percentage recovery of the other two 
sugars were not normally distributed, the data were first subjected to a natural 
logarithmic transformation. We used repeated measures ANOVA to compare 
the two time points (T12 and T24) using dexamethasone as between subject 
factor.  
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Based on a previous study6 that found a mean (SD) L/R ratio of 0.047 (0.018), a 
prospective analysis showed that we needed a sample size of 34 to detect a 




Table 1 shows patients characteristics. Ventilator hours are similar in both 
groups. Inotropic scores are not significantly different either between the two 
groups at the two time periods or within each group. The total fluid balance 
over the 36 hours study period was not significantly different between the two 
groups.  The type of operations performed in each group is shown in table 2. 
Table 3 shows the L/R ratios and percentage recovery of the four sugars 
throughout the study period together with the P value for each parameter. 
Differences in L/R ratios between the two groups were statistically significant. 
Differences in percentage recovery for rhamnose and 3-O-Methyl-D-Glucose 
were also significant between the two groups. There were no significant 




                               No dexamethasone       Dexamethasone    P values 
 
Number of patients           17   17             
Age (months)              12 (5 - 19)  4 (2 - 6)  0.02  
Sex (M/F)                        6/11         7/10   0.46  
Weight (kg)        7 (5 – 9)  5 (4 - 6)          0.01 
Surgery time (min)     181 (152 – 211) 190 (145 – 234) 0.65  
Bypass time (min)        118 (100 – 135) 118 (87 – 149) 0.66          
Aortic clamp time (min)   64 (46 – 83)  78 (52 – 104) 0.58  
Ventilator hours        52 (33 – 71)  81 (27 – 135) 0.79 
Inoscore    4 (2 – 6)  7 (2 – 11)  0.83 
Inoscore 24 hours   6 (3 – 10)  7 (1 – 13)  0.58 
Balance (ml kg-1)   29 (3 – 55)  33 (12 – 54)  0.89 
 








             No dexamethasone      Dexamethasone 
   
VSD  7   6 
ToF  1   1 
TAPVC  2   2 
Arterial switch  0   4 
Rastelli  0   1 
PA, MAPCA  0   1 
AVSD  2   0 
AVA  1   0 
BCPA  2   1 
MVA  2   1 
Total  17   17 
 
 
Table 2: Surgical procedures. Ventricular septal defect (VSD), Tetralogy of Fallot (ToF), 
Total anomalous pulmonary venous connection (TAPVC), Atrioventricular septal defect 
(AVSD), aortic valve anuloplasty (AVA), bidirectional cavopulmonary anastomosis (BCPA), 
mitral valve annuloplasty (MVA), major aortopulmonary collateral arteries (MAPCA), 
pulmonary atresia (PA). 
 
 
Urea and creatinine concentrations remained within the normal clinical range 
throughout the study period. In the control group urea concentrations (normal 
range 0.7 to 6.7 mmol l-1) were 4.8 (4 – 5.5) mmol l-1 preoperatively, 4.1 (3.4 – 
4.8) mmol l-1 immediately after the operation and 5.9 (4.9 – 6.8) mmol l-1 24 h 
later. In the dexamethasone group there were 4 (3.4 – 4.6) mmol l-1 
preoperatively, 4 (3.3 – 4.7) mmol l-1 immediately after the operation and 5.5 
(4.7 – 6.3) mmol l-1 24 h later. Creatinine concentrations (normal value less than 
70 µmol l-1) were in the control group 41 (37 – 45) µmol l-1 preoperatively, 40 
(37 – 44) µmol l-1 immediately after the operation and 52 (41 – 63) µmol l-1 24 h 
later.  
 
In the dexamethasone group there were 31 (25 – 38) µmol l-1 preoperatively, 31 
(26 – 37) immediately after the operation and 34 (28 – 39) µmol l-1 24 h later. 
None of the patients developed acute renal failure during the study period. 
Figures 1 to 5 are graphical representations of the changes in L/R ratios, and 
percentage recovery for lactulose, rhamnose, D-xylose and 3-O-methyl-D-








                             T0                    T12                         T24         P value 
L/R ratios 
No dexamethasone  0.57 (0.24 – 0.91) 0.77 (0 – 1.64) 0.46 (0.06 – 0.85) 
Dexamethasone 0.76 (0.35 – 1.17)  0.29 (0.17 – 0.42) 0.17 (0.08 – 0.15)  0.019 
 
Lactulose 
No dexamethasone 0.07 (0.02 – 0.12)   0.31 (0.22 – 0.4)     0.87 (0.51 – 1.23)  
Dexamethasone    0.08 (0.02 – 0.14)   0.62 (0.34 – 0.89) 1.07 (0.11 – 2.04)  0.056 
 
Rhamnose 
No dexamethasone 0.16 (0.02 – 0.30)   1.44 (0.68 – 2.2)     4.59 (2.23 – 6.94)  
Dexamthasone 0.16 (0.02 – 0.31)   3.02 (1.36 – 4.69) 6.18 (3.35 – 9)      0.047 
 
D-xylose 
No dexamethasone 0.29 (0.14 – 0.45)   1.58 (0.42 – 2.75)    5.69 (2.41 – 8.96)  
Dexamethasone 0.34 (0.08 – 0.60)   2.96 (1.83 – 4.09)    5.47 (2.59 – 8.34)  0.056  
 
3OMG 
No dexamethasone 0.38 (0.12 – 0.64)   3.37 (1.21 – 5.54)    14.42 (6.19 – 22.6)  
Dexamethasone 0.33 (0.09 – 0.57)   7.32 (3.32 – 11.33)  13 (6.59 – 19.42)   0.041  
 
Table 3: Lactulose/rhamnose ratios (L/R) and percentage recovery for lactulose, rhamnose, 
D-xylose and 3-O-methyl-glucose (3OMG) without and with dexamethasone. Values are 
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Fig 1: Changes in L/R ratios in both groups. Values expressed as mean 95% CI. (●) T0, (■) 


























Fig 2: Changes of lactulose percentage recovery in both groups. Values expressed as mean 



























            *
 
Fig 3: Changes of rhamnose percentage recovery in both groups. Values expressed as mean 

























Fig 4: Changes of D-xylose percentage recovery in both groups. Values expressed as mean 
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Fig 5: Changes of 3-O-D-Methyl-Glucose percentage recovery. Values expressed as mean 95% 




We have shown in this study that dexamethasone given before 
cardiopulmonary bypass starts reduces postoperative gut permeability as 
assessed by the DSPT. There was an age and weight difference between the two 
groups. This could be seen as a limiting factor in the interpretation of the 
results. Univariate analysis showed that both variables did not influence either 
L/R ratios or percentage recovery of the other two sugars. The DSPT has been 
used to assess intestinal function in healthy neonates, in whom the L/R ratios 
were around 0.05.5 Similar values were found in healthy children; range 0.023 – 
0.074 and mean (SD) 0.047 (0.018).6  
 
Gut permeability has been investigated in adult patients undergoing coronary 
artery bypass surgery.17 L/R ratios increased immediately after surgery returning 
to normal approximately 48 h after the surgical procedure. The DSPT has also 
been used to test the beneficial effects of dopexamine over dopamine in the 
splanchnic circulation during adult coronary bypass surgery.18 
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The accuracy of the DSPT relies on the complete collection of urine samples 
during the study period. This is a limiting factor on the applicability of the test 
in non-cooperative patients without a urinary catheter. A high percentage of 
patients are discharged to the ward the day after surgery with the consequent 
removal of urinary catheters. For this reason we performed the test during the 
first 24 hours after the operation.  
 
There has been criticism concerning the interpretation and significance of the 
DSPT in the literature.19,20 In an animal model it was shown that fluid loading 
increased the L/R ratios independent of changes in intestinal permeability. Rats 
received in an 8-hour period a fluid bolus equivalent to twice the daily fluid oral 
intake. Put into perspective, this means an infant of 10 kg would receive in an 8-
hour period approximately 2 litres fluid intravenously. We carefully 
documented the fluid balance during the study period. On average patients 
received less than the daily maintenance fluid expected for their age. 
 
The DSPT relies on the assumption that when lactulose and rhamnose are 
combined in the test solution at a fixed concentration ratio, the effect of 
preabsorption factors (gastric emptying, dilution by secretions, intestinal 
transient time) and postabsorption factors (systemic distribution and renal 
clearance) will apply equally to both. Therefore the L/R ratio is only influenced 
by the difference in gut permeability for each molecule.21 Percentage recovery 
of single markers may be influenced not only by the permeability of the 
intestinal mucosa but also by pre and postabsorption factors. D-xylose and 3-O-
methyl-D-glucose provide information about the functional state of the intestinal 
mucosa while the L/R ratio is a reflection of the mucosal integrity at the 
morphological level. Percentage recoveries for D-xylose and 3-O-methyl-D-
glucose did not differ substantially between the two groups.  
 
There is a trend towards normality through the study period although at T24 
percentage recoveries for both sugars are far from values expected in healthy 
children. Our study has shown that the use of dexamethasone improved gut 
permeability at the morphological level in our patients. However we have no 
explanation as to why dexamethasone did not affect the intestinal barrier at the 
functional level. A L/R ratio of 0.46 is nearly ten times the normal value and is a 
reflection of a highly permeable intestinal mucosa. If this implies that the patient 
is at higher risk for intestinal bacterial translocation and subsequent sepsis or 
intestinal ischemia is not clear. The converse is surely true. Patients diagnosed 
with necrotizing enterocolitis have consistently high L/R ratios.22  
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A likely explanation for our results is the effect that dexamethasone exerts in 
the postoperative production of proinflammatory cytokines. The concentration 
of proinflammatory cytokines decreases when steroids are used before CPB 
starts. This has been demonstrated consistently by a number of studies.23,11 
Several cytokines, including interleukin 1 (IL-1), IL-4, IL-6, IL-10, interferon γ 
(IFN-γ), and tumour necrosis factor, have been reported to increase intestinal 
permeability in vitro.3 IL-6 in particular may be a mediator of intestinal mucosal 
injury in various conditions associated with transient mesenteric hypoperfusion 
and subsequent inflammation.24  
 
A combined administration of steroids hours before the operation plus its 
addition to the pump prime appears to be more beneficial.25 Giving steroids 
intravenously to patients hours before the surgical procedure is however, often 
difficult for technical and logistical reasons. It has been standard practice in our 
institution to use dexamethasone during induction of anaesthesia only in 
patients undergoing a period of circulatory arrest.  
 
The results of the present study are an encouragement to investigate if adding 
steroids to the pump prime may provide a better and/or faster improvement in 
gut permeability. Nevertheless the use of dexamethasone in paediatric cardiac 
surgery remains a controversial issue. Lindberg and colleagues26 stated that 
omitting the use of dexamethasone in children weighing less than 10 Kg 
scheduled for cardiac surgery is unethical. Schroeder and colleagues25 accepted 
that the lack of a control group without methylprednisolone is a limiting factor 
in their study. It is according to them standard practice to use steroids in these 
patients. However there are no prospective or retrospective cohort studies that 
clearly show the influence of steroids on the clinical postoperative course. In the 
present study none of the patients in the control group developed 
gastrointestinal complications in the postoperative period and the clinical 
parameters measured were not affected by dexamethasone.  
 
Using dexamethasone to improve intestinal function is not a new concept. As 
early as 1984, Bauer and colleagues noticed a reduction in the incidence of 
necrotizing enterocolitis after prenatal glucocorticoid therapy.27 Animal models 
have shown repeatedly that in the immature animal dexamethasone reduces 
bacterial translocation in the gut and increases the length of the small 
intestine.28 The use of dexamethasone (0.5 to 1 mg kg-1 per day for several 
days) to treat or prevent chronic lung disease in preterm infants is discouraged 
after intensive review of the literature.29 Our patients were not premature, were 
exposed to enteral feeding, and their intestinal wall was far from immature.  
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The mechanisms by which dexamethasone exerts its effects in the intestinal 
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Objective: Intestinal mucosal ischemia can occur during and after cardiac 
surgery. Severe decreases in mucosal perfusion may be a causative factor for 
postoperative mortality or complications such as necrotizing enterocolitis (NEC). 
Mesenteric perfusion is challenged preoperatively due to an imbalance between 
the systemic and pulmonary circulations, and intraoperatively due to 
hypothermic circulatory arrest. We have investigated gut permeability in seven 
patients undergoing stage I of the Norwood procedure, applying the dual sugar 
permeability test (DSPT) with L-rhamnose and lactulose. 
 
Design: Seven patients with hypoplastic left heart syndrome (HLHS): clinical 
presentation, gut permeability findings and outcome. 
 
Setting: A ten bed mixed paediatric intensive care unit in a university hospital. 
 
Patients: Seven patients admitted for postoperative care after cardiac surgery. 
 
Interventions: Determination of gut permeability with the dual sugar 
permeability test using lactulose and rhamnose. Intestinal permeability was 
measured after induction of anaesthesia and 12 h and 24 h later. 
 
Measurements and Main Results: All patients had abnormal lactulose/rhamnose 
ratios. One patient, who had a lactulose/rhamnose ratio 12 hours after surgery 
of 2.3 (46 times normal), developed NEC postoperatively and died three days 
after surgery. 
  
Conclusions: Gut permeability as assessed by the DSPT is abnormal in patients 
with HLHS up to 24 hours after surgery. L/R ratios 46 times the normal value 
reflect a highly permeable small intestine. This may be a sign of a low output 













Intestinal mucosal ischemia can occur in infants and children during and after 
cardiopulmonary bypass (CPB). Severe decreases in mucosal perfusion may 
contribute to postoperative mortality or complications such as necrotizing 
enterocolitis (NEC). Infants exposed to profound hypothermia and circulatory 
arrest may be at particular risk of developing splanchnic ischemia in the 
perioperative period. The effects of these insults can be evaluated by measuring 
gut permeability using the dual sugar permeability test (DSPT). 
 
In the DSPT intestinal permeability is evaluated by measuring the urinary 
excretion of orally administered water-soluble, non-degradable test molecules. 
This barrier function test is based on the comparison of intestinal permeation of 
larger molecules (lactulose) with that of smaller molecules (L-rhamnose) by 
measuring the ratio of their urinary excretion. These molecules follow different 
routes of intestinal permeation: the larger molecules are assumed to permeate 
paracellularly, the smaller molecules transcellularly. Preabsorption factors such 
as gastric emptying, dilution by secretion and intestinal transit time, and post-
absorption factors such as systemic distribution and renal clearance are assumed 
to affect both molecules equally. Therefore, the urinary excretion ratio is 
considered a parameter for intestinal permeability per se. Four saccharides, 3-O-
methyl-D-glucose, D-xylose, L-rhamnose and lactulose are employed to assess 
active carrier-mediated, passive carrier-mediated, transcellular, and paracellular 
transport, respectively, in the small intestine. 
 
Intestinal permeability is considered to be normal if the lactulose (% 
recovery)/rhamnose (% recovery) (L/R) ratio is lower than 0.05.1,2 We report 
here the results of the dual sugar permeability test (DSPT) in seven patients 
undergoing repair of hypoplastic left heart syndrome (HLHS).  
 
Materials and Methods 
 
After approval from the local ethics committee and written informed consent 
from parents seven patients were prospectively investigated. All patients 
presented at term with HLHS. A standard anaesthesia was used and the same 
surgeon performed all the operations. Enteral feeding was started one day after 
surgery. 
  
After induction of anaesthesia (T0), 2 mL/kg of the sugar solution was 
administered through a nasogastric tube. Urine was subsequently completely 
collected for 3 h, the total volume was recorded and samples were stored at -20° 
C until analysis.  
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This process was repeated 12 (T12) and 24 h (T24) after induction of 
anaesthesia. The sugar solution contained 3-O-methyl-D-glucose (2 g/L), D-
xylose (5 g/L), L-rhamnose (10 g/L) and lactulose (50 g/L). The osmolarity was 
approximately 240 mOsm/L.  
 
Sugar concentrations in urine were determined by gas chromatography 
following a slight modification3 of the procedure described by Jansen et al.4 
Briefly, to an aliquot of urine corresponding to 0.5 µmol of creatinine, 30 µg 
ribitol and 10µg trehalose (Sigma-Aldrich, St. Louis, USA) were added as 
internal standards for the determination of rhamnose and lactulose respectively. 
The sample was dried, derivatized with 300µl Tri-Sil TBT (Pierce, Rockford, 
USA) at 100° C and partly hydrolyzed with water. Subsequently the intact sugar 
trimethylsilyl (TMS) derivatives were extracted with hexane and after 
concentrating, gas chromatographic analysis was performed on a 30 m capillary 
fused silica HP-1 column (Agilent, Palo Alto, USA) using split injection. 
Quantification was performed after the construction of standard addition 
calibration curves. Renal function was measured the day before the operation, 




Data were analyzed with the statistical package SPSS v10. Data are presented as 
mean (95% confidence intervals). Because L/R ratios were not normally 
distributed, the data were first subjected to a natural logarithmic transformation. 




Table 1 shows the L/R ratios and durations of cardiopulmonary bypass, 
circulatory arrest and aortic clamp times. Six patients had uneventful stays in 
the intensive care unit, and were mechanically ventilated for between two and 
five days. Patient 4 died of NEC three days after the surgical procedure. Patient 
5 was readmitted to the pediatric intensive care unit thirteen days after 
discharge with severe cardiac failure requiring cardiopulmonary resuscitation, 
which was unsuccessful. The cause of the cardiac failure was never diagnosed 
although severe sepsis was suspected. Table 2 shows amount of inotropic 
support used immediately after admission to the pediatric intensive care unit 12 




   L/R Ratios      Bypass (min)   Arrest (min)  Clamp (min) 
  T0    T12       T24 
Patient 1 0.18 0.08 0.22 300 80  270 
Patient 2 1.55 0.63 0.19 180 80  80 
Patient 3 0.04 0.14 0.11 162 65  87 
Patient 4 - 2.30 - 238 96  92 
Patient 5 27.6 2.37 0.23 345 150  174 
Patient 6  0.20 0.57 0.23 140 26  71 
Patient 7 0.25 0.33 - 180 88  88 
 
Table 1: Lactulose/Rhamnose (L/R) ratios during the three study periods. Missing values are 
due to the volume of urine being too small to perform the test. Patient 4 developed NEC 
postoperatively. 
 
    
                            A B C   
Patient 1  15 15 19 
Patient 2  10 15 5 
Patient 3  0 10 10 
Patient 4  10 10 10 
Patient 5  110 117.5 125 
Patient 6  7 7 14 
Patient 7  5 5 5 
 
Table 2: Inotropic scores were calculated as the sum of all inotrope doses correcting for 
potency (dopamine, dobutamine =1, milrinone = 15, epinephrine = 100), immediately after 
admission to the paediatric intensive care unit (A), 12 h (B) and 24 h (C) later. 
 
L/R ratios were at T0 0.44 (0 – 1.21), at T12 0.91 (0 – 1.83) and at T24 0.19 (0.13 
– 0.25).  Changes were statistically significant (P < 0.034). Subsequent parameter 
estimate analysis showed a highly significant difference at T24 (P < 0.002). Urea 
concentrations (normal range 0.7 to 6.7 mmol/L) were 5.5 (2.6 – 8.3) mmol/L 
preoperatively, 3.35 (2 – 4.6) mmol/L immediately after the operation and 5.4 
(3.2 – 7.6) mmol/L 24 h later. Creatinine concentrations (normal value less than 
70 µmol/L) were 61 (45 – 77) µmol/L preoperatively, 58 (51 – 66) µmol/L 
immediately after the operation and 76 (69 – 84) µmol/L 24 h later. None of the 






To our knowledge this is the first time that gut permeability has been 
investigated in neonates undergoing a period of circulatory arrest. CPB has 
been shown to temporarily increase gut permeability in adult patients 
undergoing coronary bypass graft surgery.5 Changes in gut permeability in the 
pediatric population have been reported recently in the literature.6 Thirty four 
patients undergoing cardiac surgery with and without cardiopulmonary bypass 
were prospectively investigated. High L/R ratios were present from the outset. 
L/R ratios decreased over the following 24 h period in patients operated without 
CPB. L/R ratios increased in patients operated with CPB 12 h after the 
operation, while 24 h later the differences were significantly higher in the group 
with CPB.  
 
L/R ratios in the present study were also above the normal value preoperatively 
and the perioperative changes are significantly different. Insufficient mesenteric 
oxygen supply due to a combination of cyanosis and preferential flow to the 
pulmonary circulation instead of the systemic circulation may justify these 
findings. Table 1 clearly shows that in two of six patients L/R ratios decreased 
after the operation. However when compared to patients undergoing cardiac 
surgery without circulatory arrest the L/R ratios tended to be higher before and 
immediately after the operation. This may be purely coincidental or may be 
due to the severity of the disease and the use of circulatory arrest during the 
surgical procedure. 
 
Of the seventeen patients undergoing surgery with CPB6 only one had L/R 
ratios similar to those found in patients 4 and 5 of the present study. The patient 
did not develop NEC but required doses of inotropes in the postoperative 
period similar to those needed by patient number 5. At the time we conducted 
the DSPT in patient 4 there were no signs of NEC. However a L/R ratio 46 
times the normal value at T12 reflected a highly permeable small intestine. It is 
unfortunate that in this patient the volume of urine was inadequate for analysis 
after induction of anaesthesia. The surgical repair in patient 5 was technically 
difficult resulting in a long circulatory arrest time and considerable inotropic 
support postoperatively. This could explain the high L/R ratio of 2.37 at T12.   
 
Neonates with congenital heart disease have a high risk of developing NEC, 
with a reported incidence in patients with HLHS between 7.6% and 10% and 
mortality above 90%.7,8  
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Enteral feeding has been proposed as a risk factor for NEC in term neonates, 
although in patients with congenital heart disease this appears not to be the 
case.8 The DSPT was performed in our patients before feeding started.  
 
L/R ratios in healthy neonates enterally fed are less than 0.05.2 Similar values 
were found in children without intestinal pathology 0.047 (0.018) (Mean (SD)).1 
This is in contrast to what it has been found consistently in patients with 
congenital heart diseases preoperatively.6 The DSPT has been previously 
applied to patients without congenital heart disease already diagnosed with 
NEC.9 The DSPT was performed in a number of occasions over a three week 
period. The highest reported value was 0.98. These patients were starved during 
the study period and received total parenteral nutrition. In the same study 
patients undergoing intestinal surgery acted as controls showing elevated L/R 
ratios as well (highest value 0.32). However L/R ratios returned to normal faster 
than in the NEC group. 
 
The DSPT has limitations. Gas chromatography is a time consuming procedure, 
but if important clinical decisions depend on the result, it can be completed in a 
matter of hours. It can also produce spurious results, such as in the first urine 
sample of patient 5 in which a very low rhamnose excretion resulted in a L/R 
ratio of 27.6. Gut permeability has not been investigated in patients suffering 
from either acute or chronic renal failure. This is a limitation to the applicability 
of the test. It is assumed that the percentage of both sugars not eliminated in the 
urine is metabolized by colonic bacteria into short chain fatty acids.10  
 
Studies in adult patients investigating the elimination of lactulose and rhamnose 
have shown that no rhamnose and little lactulose (1.56% of the ingested amount) 
are present in the urine after 12 h collection.11 It is unlikely that gut 
permeability assessment at T12 and T24 may be affected by previous 
instillations. L/R ratios are not affected if the urinary collection period is three 




Gut permeability as assessed by the DSPT is abnormal in patients with HLHS 
up to 24 hours after surgery. L/R ratios 46 times the normal value reflect a 
highly permeable small intestine. This may be a sign of a low output state and 
may help to identify patients at risk of developing NEC. Pre-emptive treatment 
of NEC before obvious clinical signs appear could have benefits in terms of 
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Until now rhamnose has been considered an inert sugar not metabolized by the 
human body. During an investigation on gut permeability in children 
undergoing cardiac surgery using the dual sugar permeability test1 (DSPT), we 
found increased concentrations of rhamnitol, a metabolite of rhamnose, in their 
urine. Four saccharides, 3-O-methyl-D-glucose, D-xylose, L-rhamnose and 
lactulose are used in the DSPT. The identity of rhamnitol was established by 
mass spectrometry. Rhamnitol also increased when an adult volunteer ingested 
the sugar solution. Our finding provides evidence that, contrary to accepted 
opinion, rhamnose is not an inert sugar but is partially metabolized into 
rhamnitol in humans. 
 
Materials and methods 
 
Our initial study1 involved 34 paediatric patients undergoing cardiac surgery 
with (n = 17) or  without (n = 17) cardiopulmonary bypass (CPB). Anaesthesia 
was standard for all patients. Two ml kg-1 of a sugar solution were instilled 
through a nasogastric tube after induction of anaesthesia, and again 12 and 24 h 
later. The test solution contained 3-O-methyl-D-glucose (2 g l-1), D-xylose (5 g l-
1), L-rhamnose (10 g l-1) and lactulose (50 g l-1). After each instillation, urine was 
completely collected through a urinary catheter for 3 h, and stored at –20 ÀC 
until analysis. One infant undergoing cardiac surgery received the sugar 
solution only once during induction of anaesthesia and urine was collected for 
24 h afterwards. A healthy adult volunteer ingested the sugar solution (2 ml kg-
1) after overnight fasting and urine samples were subsequently collected at 4 h, 
8 h, 16 h and 24 h.   
  
Sugar concentrations in urine were determined by gas chromatography and a 
full description of the method can be found elsewhere1. The identity of 
rhamnitol was confirmed by comparison of retention time and electron-
ionization mass spectrum with that of authentic rhamnitol (Sigma-Aldrich, St. 
Louis, USA). Data are presented as mean (95% Confidence Intervals). After a 




Table 1 shows the percentage recovery of rhamnose and the percentage of 
ingested rhamnose metabolized into rhamnitol in urine in the two groups 
(Table 2 gives the absolute values). As can be seen from the data both 
parameters increase in the consecutive 3 h urine collections.  
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The patientÊs weight (kg) was 4.8 (2.5-15) for the non-CPB group and 6 (4-14) for 
the CPB group. Rhamnitol was not detectable in the sugar solution supplied by 
the pharmacy. Rhamnitol was detected in trace amounts (< 0.03 mg/3 h) in 
urine of paediatric patients investigated for inborn errors of metabolism. In the 
patient where the sugar solution was administered only once, 12.2% (9.7 mg) of 
the ingested rhamnose was recovered unaltered and 1.3% (1.03 mg) was 
recovered as rhamnitol. 
 
    T0           T12        T24 
No CPB 
Rhamnose % 0.34 (0.2 – 0.48) 3.4 (1.4 – 5.4) 4.6 (2.5 – 6.8) 
Rhamnitol %  0.03 (0 – 0.48) 0.23 (0.1 – 0.37) 0.68 (0.4 – 1) 
 
CPB 
Rhamnose % 0.16 (0.02 – 0.3) 1.4 (0.68 – 2.2)  2.5 (1.3 – 3.7) 
Rhamnitol %  0.02 (0.06 – 0.03) 0.13 (0.08 – 0.2) 0.76 (0.4 – 1.1) 
 
Table 1: Percentage of ingested rhamnose recovered in urine and percentage of rhamnose 





   T0   T12   T24 
 
CPB  0.03 (0.01 - 0.06)   0.2 (0.07 - 0.33)   0.89 (0.45 - 1.33) 
 
No CPB 0.02 (0.005 - 0.029)   0.23 (0.11 - 0.36)   0.69 (0.42 - 0.95)   
 
Table 2: Total amount of Rhamnitol in mg in urine collected over a three hour period. 
Values expressed as mean (95% confidence intervals). 
 
 
In the adult volunteer rhamnitol was present in the urine after the ingestion of 
the sugar solution. In urine collected 4 h after loading, 5.1% (76.8 mg) of the 
ingested rhamnose was recovered and 0.11% (1.7 mg) was found to be 
metabolized into rhamnitol. In the whole 24 h urine these figures were 6.7% (107 







Assessment of gut permeability using the DSPT was introduced in the late 
seventies2. The L/R ratio is considered to be a parameter for intestinal 
permeability. The strength of the test relies on the fact that both are assumed to 
be inert sugars not metabolized by the organism. In humans, the proportion of 
rhamnose not excreted in the urine is assumed to be fermented by colonic 
bacteria into short chain fatty acids (acetate, propionate and butyrate)3. Some 
bacteria metabolize rhamnose into rhamnulose but not to rhamnitol4.  
 
However we have consistently found rhamnitol in the urine of patients in our 
study. Traces of rhamnitol were generally found in urine of children who were 
screened for inborn errors of metabolism. It is likely that the conversion of 
rhamnose into rhamnitol by the human body follows a pathway similar to what 
has been proposed for another previously thought inert sugar (L-arabinose)5. A 
possible metabolite such as rhamnoate however was not present. The findings 
in the adult volunteer as well as the data presented in table 1 indicate that 
rhamnose is slowly metabolized. Therefore almost certainly the rhamnitol found 
in the urine of the patients after the second and third instillation is largely a 
metabolite of the previous dose(s). 
 
Xylitol was also increased in the urine samples of the patients in this study (data 
not shown), indicating that xylose is also not an inert sugar. The DSPT is used 
as a research tool in human and animal studies. The addition of rhamnitol to 
rhamnose can reduce the L/R ratio strongly. Lactulose/Rhamnose ratios (L/R) 
changed significantly when rhamnitol was added to rhamnose in our previous 
study; group with CPB (P < 0.02) 0.57 (0.24 – 0.91) (without rhamnitol) and 0.49 
(0.22 – 0.76) (with rhamnitol). Group without CPB (P < 0.01) 0.6 (0.36 – 0.85) 
(without rhamnitol) and 0.55 (0.32 – 0.78) (with rhamnitol) (normal L/R <0.05).  
This may be clinically irrelevant when the L/R ratios are as high as in our 
investigations. However it must be taken into consideration when L/R ratios are 
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Background: Paediatric cardiac surgery is associated with some degree of 
myocardial injury. Ischaemic preconditioning (IP) has been widely investigated 
in the adult population. Volatile agents have been shown to simulate IP 
providing extra protection to the myocardium during adult cardiopulmonary 
bypass while propofol seems to act through different mechanisms. IP has not 
been investigated in the paediatric population to the same extent. Cardiac 
troponin T (cTnT) is a reliable marker of myocardial injury in neonates and 
children. We have investigated the relationship between three anaesthetic 
agents, midazolam, propofol and sevoflurane, and postoperative production of 
cTnT. 
 
Methods: Ninety patients undergoing repair of congenital heart defect with 
cardiopulmonary bypass were investigated in a prospective randomized study. 
cTnT was measured four times during the first 24 hours following admission to 
the paediatric intensive care unit. Other parameters measured included arterial 
blood gases, lactate, fluid balance, use of inotropic drugs, PaO2/FiO2 ratio and 
ventilator hours. 
 
Results: cTnT was elevated in all three groups throughout the study period. The 
differences between the three groups were not statistically significant. Eight 
hours after admission to the intensive care unit cTnT concentrations tended to 
be higher in the midazolam group (mean (95% confidence intervals)); 2.7 (1.9 – 
3.5) ng ml-1 . Patients receiving a propofol based anaesthesia had similar 
concentrations 2.6 (1.7 – 3.5) ng ml-1 while those receiving sevoflurane tended 
to have a lower cTnT production 1.7 (1.3 – 2.2) ng ml-1.  
 
Conclusions: Midazolam, propofol and sevoflurane seem to provide equal 
myocardial protection in paediatric cardiac surgery when using cTnT as a 












During repair of a congenital heart defect the child is exposed to myocardial 
hypoxia. Exposing the adult myocardium to brief periods of ischaemia and 
reperfusion induces greater tolerance to a subsequent more prolonged 
ischaemic insult, a phenomenon known as ischaemic preconditioning (IP). 
  
Animal experiments have shown that the effects of ischaemic preconditioning 
are mimicked by inhalational anaesthetics1, morphine2, and possibly other 
opioids. This is often referred to as anaesthetic preconditioning. The use of 
inhalational anaesthetics improves clinical and biochemical parameters after 
coronary artery bypass surgery.3,4 The subject has been reviewed extensively.5,6 
There is little available information as to whether IP also occurs in paediatric 
patients. IP is absent in rats at birth and only develops in the second week of 
postnatal life.7 Preconditioning can be induced in isolated perfused immature 
rabbit hearts.8 It has been suggested that the normoxic paediatric heart is less 
likely than the adult heart to undergo injury with bypass or surgical ischaemia.9 
Recent studies, however, have suggested that the paediatric myocardium is 
more sensitive to hypoxia and cardioplegic arrest than the adult one.10 On the 
other hand cyanotic patients are  exposed to high concentrations of oxygen 
when bypass starts (similar to reperfusion injury). 
 
The effect of halogenated agents and propofol on ischaemia and reperfusion 
injury has been widely investigated in adults. Midazolam has not been 
investigated to the same extent and information about its potential benefits or 
lack thereof is scarce. Midazolam, sevoflurane and propofol are three 
anaesthetic agents commonly used in paediatric practice.  
 
Cardiac troponin T (cTnT) is a specific marker of myocardial infarction.11 It is 
also a reliable marker of myocardial injury in the paediatric population.12 There 
is no information in the literature about the relationship between postoperative 
production of cTnT in children and the anaesthetic agents, midazolam, 
propofol and sevoflurane.  In this study we investigated whether midazolam, 
propofol or sevoflurane afford equal myocardial protection during paediatric 
cardiac surgery, as assessed by postoperative cTnT production. 
 
Materials and Methods 
 
After approval by the hospital ethics committee and parental consent 90 
patients were prospectively investigated. cTnT was measured four times during 
the first 24 h following admission to the paediatric intensive care unit. This is 
standard practice in our institution.  
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Patients were randomized using standard randomization tables to receive either 
midazolam, propofol or sevoflurane as the main anaesthetic agent. We used a 
process of minimization to achieve similar number of patients for each surgical 
procedure. The first patient for each operation is allocated at random. For each 
subsequent patient we determined which treatment would lead to a better 
balance between the groups with respect to the type of operation. The patient is 
then randomized using a weighting system in favour of the treatment which will 
minimize the imbalance.13 Measurement of cTnT was done by the hospital 
clinical chemistry laboratory, and the analysts were unaware of the conduct of 
this study.  
 
Patients received premedication consisting of oral atropine (0.02 mg kg-1) and 
midazolam (0.5 mg kg-1) 30 min before induction of anaesthesia. Anaesthesia 
was induced with sevoflurane followed by a bolus of sufentanil (1 øg kg-1) and 
pancuronium (0.2 mg kg-1). For maintenance of anaesthesia, (30 patients in each 
group) patients received either a continuous infusion of midazolam (0.2 mg kg-1 
h-1), a continuous infusion of propofol (6 to 8  mg kg-1 h-1), or  an end tidal 
concentration of sevoflurane of 2 to 3% throughout the operation.  
 
Each patient received a continuous infusion of sufentanil (2 øg kg-1 h-1) 
throughout the operation. The lungs of the patients were mechanically 
ventilated with a mixture of oxygen and air. Mechanical ventilation was 
maintained until the start of cardiopulmonary bypass (CPB). After heparin 
administration (3 mg kg-1) and aorta cannulation, CPB was instituted with a 
Dideco hollow fibre oxygenator with a blood flow between 200 and 300 ml kg-1 
min-1.  
 
The prime volume 325 to 750 ml according to the patientÊs weight, contained 
lactate free RingerÊs solution, albumin, mannitol, blood and heparin. Body 
temperature during bypass was maintained at 28 °C except for patients 
undergoing circulatory arrest who were cooled to 20 °C during the period of 
circulatory arrest. Patients underwent modified ultrafiltration at the end of the 
bypass. 
 
Blood samples (0.5 ml) were taken immediately after admission, and 8, 15 and 
24 h after admission to the paediatric intensive care unit. Samples were 
collected in a Gel-Microtainer tube and immediately analysed by the hospital 
clinical chemistry department using the Elecsys Modular E170 
immunochemistry analyzer (Cardiac Troponin T, Roche Diagnostics, 
Mannheim).  
 71
Briefly, this immunoassay employs two monoclonal antibodies specifically 
directed against human cardiac troponin T. The antibodies recognize two 
epitopes located in the central part of the cardiac troponin T protein. The lower 
detection limit is 0.01 ng ml-1. Ten patients admitted to the paediatric intensive 
care unit before surgery had cTnT levels measured as part of standard clinical 
practice. 
 
Arterial oxygen tension (PaO2), pH, base excess (BE), bicarbonate and lactate 
were measured immediately after admission to the intensive care unit and 24 h 
later (Chiron 865, Bayer, Mijdrecht, The Netherlands). Fluid balance in the 36 h 
following admission, and ventilator hours were also recorded. 
 
The type of vasoactive drugs and their amount were recorded after admission 
to the intensive care unit and 24 h later. To quantify inotropic support, inotrope 
scores were calculated as the sum of all inotrope doses correcting for potency 
(dopamine, dobutamine = 1, milrinone = 15, epinephrine = 100).14,15 Fluid 
intake (including crystalloids, colloids and blood products), output (urine, blood 
and serous fluid loss) and fluid balance were recorded over a 36 h period 




In a retrospective analysis of fifteen patients the mean (SD) cTnT 
postoperatively was 1.92 (2.13) ng ml-1. A power analysis based on these 
findings showed that we would need 90 patients to detect a difference in cTnT 
of 2 ng ml-1 with α = 0.05 and a power of 95%.   
 
Data were analysed with the statistical package SPSS v10, and are summarized 
as mean and 95% confidence intervals. PatientÊs characteristics (age, weight, 
surgery times and ventilator hours) and fluid balance were analyzed with 
ANOVA Bonferroni correction for post-hoc analysis. Because cTnT 
concentrations were not normally distributed, the data were first subjected to a 
natural logarithmic transformation before analysis by repeated measures 
ANOVA with the Greenhouse-Geisser correction. Differences (T8) from 
baseline values were analysed with ANOVA Bonferroni correction for pos-thoc 
analysis. Blood gas variables were also analyzed with repeated measures 
ANOVA. Categorical data were analysed using the Chi-squared test. 
Correlation coefficients between variables were calculated using Pearson test for 
normally distributed data and Spearman test for non normally distributed data. 




The groups were comparable with respect to sex, age, weight, type of surgery, 
and cardiopulmonary bypass, aortic cross clamp and circulatory arrest times 
(Table 1). The number of cyanotic patients and those undergoing a 
ventriculotomy were well matched in each group. Table 2 shows the type of 
operations performed in each group. In the 10 patients from whom blood 
samples were obtained preoperatively (midazolam = 3, propofol = 4 and 
sevoflurane = 3), cTnT concentrations were less than 0.02 ng ml-1. These 
patients were admitted to the intensive care unit preoperatively for logistical 
reasons the day before surgery. Table 3 shows cTnT concentrations throughout 
the study period in the three groups. Figure 1 shows the changes in cTnT in the 
three groups throughout the study period. Although the cTnT concentrations in 
the midazolam group tended to be higher at T8 than in the other two groups, 
the differences were not significant.  
 
 
 Midazolam   Propofol     Sevoflurane 
N    30       30         30 
Age (months)    6 (0.9 – 11)       14 (2.9 – 26)       13 (5.4 – 21) 
Sex (M/F)    17/13       20/10         15/15 
Weight (kg)    5 (3.8 – 6.2)       7.5 (4.8 – 10)   6.8 (5.3 – 8.4) 
Surgery time (min)    183 (159 – 208)   190 (166 – 215)   194 (172 – 216) 
Bypass time (min)    114 (90 – 137)     122 (99 – 144)   120 (102 – 138) 
Clamp time (min)    77 (56 – 98)         74 (53 – 96)         67 (50 – 85) 
Arrest time (min)    9 (0 – 19)       9 (0 – 18)         7 (0 – 13) 
Ventriculotomy (Y/N)   9/21       7/23         10/20 
Cyanotic (Y/N)    14/16      17/13         16/14 
Ventilator hours    87 (60 – 115)      106 (59 – 153)      84 (48 – 120) 
 
Table 1: Patient characteristics. Values are expressed as mean (95% confidence intervals). 
 
 
The differences of cTnT concentrations between T8 (maximum peak) and 
baseline for the three groups were (mean (95% Confidence Intervals)) 0.85 (1.2 – 
1.49) ng ml-1 for midazolam, 0.7 (0.13 – 1.27) ng ml-1 for propofol and 0.05 (0 – 
0.38) ng ml-1 for sevoflurane. Between groups variations were not statistically 
significant (p < 0.49) either. 
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There were no significant differences in PaO2, pH, base excess, bicarbonate or 
lactate between the groups. The differences in fluid balance, PaO2/FiO2 ratios 
and ventilator hours in the 36 h following admission to the PICU also were not 
significantly different. There were no differences between the groups in the use 
of inotropic drugs on admission to the intensive care or 24 hours later. One 
patient in the sevoflurane group died 30 days after readmission to the intensive 
care unit due to irreversible cardiac failure. 
 
 
 Midazolam Propofol Sevoflurane 
    
VSD 8 8 6 
ToF 3 3 6 
TAPVC 2 1 2 
Arterial switch 6 6 3 
Norwood stage I 2 3 2 
IAA 1 0 1 
Pulmonary homograft 2 1 2 
Fontan 1 2 2 
AVSD 2 3 3 
Aortic stenosis 2 1 0 
Glenn 1 2 2 
MVR 0 0 1 
Total 30 30 30 
 
Table 2: Surgical procedures. Ventricular septal defect (VSD), Tetralogy of Fallot (ToF), 
Total anomalous pulmonary venous connection (TAPVC), Interrupted aortic arch (IAA), 





         T0        T8        T15      T24 
     
Midazolam 1.9 (1.5 – 2.3) 2.7 (1.9 – 3.5) 2.4 (1.8 – 2.9) 1.9 (1.5 – 2.3) 
Propofol 1.9 (1.4 – 2.4) 2.6 (1.7 – 3.5) 2.3 (1.5 – 3.1) 2.1 (1.3 – 2.8) 
Sevoflurane 1.7 (1.3 – 2.1) 1.7 (1.3 – 2.2) 1.6 (1.2 – 1.9) 1.5 (1.2 – 1.8) 
 
Table 3: Cardiac troponin T concentrations (ng ml-1) in blood immediately after admission to 























Fig 1: cTnT concentrations in the three groups at the four different time points. Values are 
expressed as mean (95% confidence intervals).T0 (●), T8 (▲), T15 (■) and T24 (▼). 
 
 
Concentrations of cTnT peaked at T8 in all three groups. Univariate analysis of 
variance showed that cTnT concentrations at this time point were not related to 
sedation, cyanosis or the use of ventriculotomy.  At T8 acyanotic patients had 
lower concentrations of cTnT than cyanotic patients in all groups although the 
differences were not significantly different. The values for acyanotic patients 
were 2.68 (1.8 – 3.5) ng ml-1 for midazolam, 2.28 (1.3 – 3.3) ng ml-1 for propofol 
and 1.67 (1.2 – 2.2) ng ml-1 for sevoflurane. The corresponding values for 
cyanotic patients were 2.84 (1.4 – 4.3) ng ml-1 for midazolam, 2.82 (1.3 – 4.3) ng 
ml-1 for propofol and 1.81 (1.1 – 2.5) ng ml-1 for sevoflurane.  
 
There was a significant correlation between ventilator hours and cTnT 
concentrations at T8 in the sevoflurane group (r = 0.45) and midazolam group 
(r = 0.50), but not in the propofol group.  There was no correlation between 




Our study shows that the postoperative production of cTnT in paediatric 
patients undergoing cardiac surgery is similar with midazolam, propofol or 
sevoflurane anaesthesia. To our knowledge this is the first time this has been 
reported. Peak concentrations of cTnT 2.7 (1.9 – 3.5) ng ml-1 (mean (95 % 
Confidence Intervals)) are similar to those reported in other studies. Immer and 
colleagues12,16  reported mean cTnT concentrations of 4.06 ng ml-1 and 5.5 ng 
ml-1 in two consecutive studies with a patient population similar to ours. 
Unfortunately they failed to mention the type of anaesthetic technique used by 
them.  
 
Hovels-Gurich and colleagues17 reported a mean value of 5 ng ml-1 in neonates 
with transposition of the great arteries undergoing arterial switch operation. 
However all these patients underwent surgery with circulatory arrest. Seven 
patients in our study underwent a similar period of circulatory arrest, with a 
maximum cTnT concentration at T8 of 3.9 ng ml-1. 
 
IP has been little investigated in children. Classical IP in rats is not present at 
birth, and the enhanced recovery of contractile function develops only at the 
end of the first postnatal week.7 Baker and colleagues found that 
preconditioning can be induced in isolated perfused normoxic immature rabbit 
hearts.8 In the same study they found that isolated immature rabbit hearts that 
were chronically hypoxic from birth could not be preconditioned, even when 
the number of occlusion periods was increased. In an animal study,18 pregnant 
rats were exposed chronically to intermittent periods of hypoxia. Their new 
born offsprings underwent periods of IP immediately after birth. Neither 
procedure in isolation increased tolerance to subsequent periods of hypoxia, 
while the combination increased cardiac tolerance.   
 
A phenomenon similar to reperfusion injury happens at the start of CPB in 
cyanotic patients. Allen and colleagues19 took biopsies of myocardial tissue in 
acyanotic and cyanotic patients before and 10 minutes after initiating bypass to 
measure antioxidant reserve capacity. In contrast to acyanotic patients, abrupt 
reoxygenation of cyanotic patients resulted in a significant depletion of 
endogenous tissue antioxidants. The effect of cyanosis on cTnT production was 
not our primary end point. Univariate analysis demonstrates that cyanosis did 
not have any influence in our results. cTnT concentrations were consistently 
higher in cyanotic patients in all three groups.  
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The differences however were not statistically significant. This is in contrast with 
two other studies20,21 where unfortunately there is no description of the 
anaesthetic technique.Preliminary data indicate that cTnT values shortly after 
surgery for congenital heart disease are potentially useful prognostic indicators 
of postoperative recovery.12,17 Once again those studies did not mention the 
type of anaesthetic agent used perioperatively.  
 
We have demonstrated in our study that only ventilator hours correlates with 
cTnT production, and this was limited to the midazolam and sevoflurane 
group. Although statistically significant the correlations are weak.  
 
Both cardiac troponin I (cTnI) and cTnT seem to evolve in a similar way after 
paediatric cardiac surgery.16 Reported baseline values for cTnT remain below 
the standard cutoff point of 0.1 ng ml-1. False pathological values of cTnT in 
patients with renal failure make cTnI theoretically a better choice. None of our 
patients developed renal failure during their admission to intensive care. 
However cTnI also has its limitations. Sasse and colleagues22 showed that for up 
to nine months after birth in healthy infants, and for up to two years in infants 
with congenital heart disease, cTnI is not expressed solely in the myocardium. 
Slow twitch skeletal muscle troponin I is expressed in variable amounts in these 
infants. 
 
Propofol decreases postischaemic myocardial mechanical dysfunction, infarct 
size and histological degeneration. It also suppresses the activity of neutrophils, 
and may therefore produce its beneficial effects by reducing free radicals, Ca2+ 
influx and neutrophil activity.23 Other studies have failed to demonstrate a 
protective effect of propofol on myocardial function during ischaemia and 
reperfusion, and it does not appear to act as a preconditioning agent.24 
 
Volatile anaesthetics improve recovery of contractile function of the stunned 
myocardium. Sevoflurane mimics ischaemic preconditioning, with an 
improvement of postischaemic contractility in isolated guinea pig hearts.25 It 
also appears to reduce myocardial infarct size and to decrease the time 
threshold for ischaemic preconditioning in dogs, through activation of 
adenosine triphosphate-regulated potassium (KATP) channels.26,27 The 
cardioprotective effect was independent of changes in coronary blood flow or a 
reduction in cardiac work. In addition to its preconditioning effects, sevoflurane 
also appears to exhibit cardioprotective effects against reperfusion injury. This 
effect has been attributed to its radical scavenging properties and the reduction 
of postischaemic adhesion of neutrophils.28 
 77
It has been suggested that sevoflurane may preserve myocardial function better 
than propofol in patients undergoing coronary artery bypass surgery.29 
Troponin I concentrations were significantly lower in the sevoflurane group 
than in the propofol group.29 Compared to propofol, anaesthesia with either 
sevoflurane or desflurane resulted in a shorter length of stay in the ICU in 
adults after coronary artery surgery.30 In our study the type of anaesthesia did 
not influence length of stay in the paediatric intensive care unit. 
 
Benzodiazepines have not been investigated extensively in the adult population, 
and we could find no references in the literature to their myocardial effects in 
paediatric cardiac surgical patients. In isolated perfused guinea pig hearts 
subjected to ischaemia midazolam reduced neutrophil adhesion to non-
ischaemic control levels.31 Adhesion of polymorphonuclear neutrophils (PMN) 
to the coronary endothelium is a crucial step in the development of ischemic 
myocardial injury. In this study ketamine and thiopental behaved in a similar 
way. Midazolam may interfere with Ca2+ influx and free radical production but 
the data is contradictory in this respect.32,33 
 
If IP occurs in children, sevoflurane seems to lack the IP-like effect 
demonstrated in the adult population.30 Propofol and sevoflurane may provide 
protection to the adult myocardium by different mechanisms. However, they 
both appear equally effective in our study. 
 
In conclusion we have demonstrated that midazolam, propofol and sevoflurane 
produce similar concentrations of cTnT postoperatively in paediatric cardiac 
surgery. Contrary to what has been published in adult patients undergoing 
coronary bypass surgery, sevoflurane did not reduce significantly cTnT 
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Objectives: Paediatric cardiac surgery is associated with a temporary rise in 
cardiac troponin T (cTnT) during the postoperative period. We have tested the 
hypothesis that dexamethasone given before cardiopulmonary bypass starts 
may have myocardial protective effects as assessed by the postoperative 
production of cTnT. 
 
Design: Prospective randomized interventional study. 
 
Setting: Paediatric intensive care unit in a university hospital. 
 
Interventions: Patients were randomly allocated to act as controls or receive a 
single dose of dexamethasone (1 mg kg-1) during induction of anaesthesia. 
Measurements and results: cTnT was measured four times postoperatively; 
immediately after admission to the paediatric intensive care unit (PICU) and at 
8, 15 and 24 h thereafter. Both groups had similar cTnT concentrations on 
PICU admission; 2 (1.56 – 2.51) ng ml-1 (mean (95% Confidence Intervals)) in 
the group without dexamethasone and 1.85 (1.55 – 2.15) ng ml-1 in the group 
with dexamethasone. Concentrations of cTnT 8 h after admission to the PICU 
were 3.08 (2.46 – 3.69) ng ml-1 in patients not receiving dexamethasone and 
1.99 (1.53 – 2.45) ng ml-1 in patients receiving dexamethasone. Overall 
differences between the two groups were significant (P < 0.035). After subgroup 
statistical analysis differences between the two groups remained significant only 
at 8 h (P < 0.005). At 15 h and 24 h after admission to the PICU differences 
were no longer significant. 
      
Conclusions: The use of dexamethasone (1 mg kg-1) before cardiopulmonary 
bypass starts is associated with a short lived significant reduction in 













The use of cardiopulmonary bypass (CPB) can induce a systemic inflammatory 
response syndrome in the postoperative period. This phenomenon is probably 
more exaggerated in the paediatric population as a greater proportion of the 
patientÊs blood is exposed to the surface of the CPB circuit.1 The 
proinflammatory response associated with the use of CPB in children has been 
reviewed extensively elsewhere.2 Within the paediatric population, neonates 
may react differently to CPB exposure, with higher proinflammatory cytokine 
production.3  
 
Corticosteroids have been used extensively in adult cardiac surgery. Patients 
given methylprednisolone before CPB started had higher cardiac indices than 
those given placebo.4 More recent studies, however, have shown that the use of 
methylprednisolone offered no clinical advantage in adults undergoing cardiac 
surgery with CPB.5 Experience with steroids in paediatric cardiac surgery, on 
the other hand, is limited. The assumption has always been that the paediatric 
myocardium is more resistant to hypoxia than the adult one. This may not be 
the case.6 
 
Steroids given before CPB starts reduce significantly the postoperative 
production of proinflammatory cytokines in children7 and may provide 
myocardial protection during cardiac surgery. The use of troponins as surrogate 
markers to assess the potential myocardial protective effect of steroids is not a 
new concept.8,9 However in those studies the investigators measured cardiac 
troponin I (cTnI). Sasse and colleagues10 showed that up to nine months after 
birth in healthy infants, and for up to two years in infants with congenital heart 
disease, cTnI is not expressed solely in the myocardium, but is also expressed 
in variable amounts from slow twitch skeletal muscle.  
 
Cardiac troponin T (cTnT) is a specific marker of myocardial infarction.11 It is 
also a reliable marker of myocardial injury in children. Cardiac troponin T 
(cTnT) concentrations rise postoperatively in paediatric patients undergoing 
cardiac surgery with CPB;12 up to three times the average cTnT that could be 
found in adult patients undergoing coronary artery bypass surgery.13  
 
We have tested the hypothesis that dexamethasone given before CPB starts may 
have myocardial protective effects as assessed by the postoperative production 
of cTnT, the inotropic support and ventilator hours necessary after surgery. 
Subgroup analysis in cyanotic and neonatal patients was also evaluated for the 




Materials and Methods 
 
After approval by the hospital ethics committee and parental consent 140 
patients were prospectively investigated. This study was conducted between 
October 2003 and December 2004. Approximately 300 paediatric patients per 
year undergo cardiac surgical procedures in our institution. Patients operated 
without CPB were not recruited. cTnT was measured four times during the first 
24 h following admission to the paediatric intensive care unit (PICU). This is 
standard practice in our institution. Patients were randomized using standard 
randomization tables to receive either dexamethasone (1 mg kg-1) during 
induction of anaesthesia or act as controls. The use of placebo is not allowed by 
our hospital ethics committee. We used a process of minimization to achieve 
similar number of patients for each surgical procedure. The first patient for each 
operation was allocated at random. For each subsequent patient we determined 
which treatment would lead to a better balance between the groups with respect 
to the type of operation. The patient was then randomized using a weighting 
system in favour of the treatment which would minimize the imbalance.15 cTnT 
concentrations were measured by the hospital clinical chemistry laboratory, and 
the analysts were unaware of the conduct of this study.  
 
The anaesthetic technique was similar for both groups. Patients received a 
premedication consisting on oral atropine (0.02 mg kg-1) and midazolam (0.5 
mg kg-1) 30 min before induction of anaesthesia. Anaesthesia was induced with 
sevoflurane followed by a bolus of sufentanil (1 µg kg-1) and pancuronium (0.2 
mg kg-1). Maintenance of anaesthesia consisted on a combined continuous 
infusion of either midazolam (0.2 mg kg-1 h-1) or propofol (6 mg kg-1 h-1), and 
sufentanil (2 µg kg-1 h-1). The lungs of the patients were ventilated with 
oxygen/air (FIO2 = 0.5). Ventilation was discontinued during CPB.  After 
heparin administration (3 mg kg-1 or 300 IU kg-1) and aorta cannulation, CPB 
was instituted with a Dideco hollow fibre oxygenator with a blood flow between 
200 and 300 ml kg-1 min-1. The prime volume, 325 to 750 ml according to the 
patientÊs weight, contained lactate-free RingerÊs solution, albumin, mannitol, 
blood and heparin. Body temperature during bypass was maintained at 28 °C 
except for patients undergoing circulatory arrest, who were cooled to 20 °C 
during the period of circulatory arrest. Patients underwent modified 
ultrafiltration at the end of the bypass. The amount of fluid ultrafiltered was 60 
(49 – 63) ml kg-1 (mean 95% Confidence Intervals).  
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In the PICU, patients were sedated with a combination of midazolam (0.1 -0.2 
mg kg-1 h-1) and morphine (10-20 µg kg-1 h-1). Our practice is not to use 
diuretics in the first 24 h after admission to the PICU. 
 
Blood samples (0.5 ml) were taken for measurement of cTnT concentrations 
immediately after admission to the paediatric intensive care unit (PICU), and 8, 
15 and 24 h after admission. Samples were collected in a Gel-Microtainer tube 
and immediately analysed using the Elecsys Modular E170 immunochemistry 
analyzer (Cardiac Troponin T, Roche Diagnostics, Mannheim, Germany). 
Briefly, this immunoassay employs two monoclonal antibodies specifically 
directed against human cardiac troponin T. The antibodies recognize two 
epitopes located in the central part of the cardiac troponin T protein. The lower 
detection limit is 0.01 ng ml-1. Ten patients admitted to the PICU before surgery 
had preoperative cTnT concentrations measured as part of standard clinical 
practice. 
 
Arterial oxygen tension (PaO2), pH, base excess (BE), bicarbonate and lactate 
were recorded immediately after admission to the intensive care unit and 24 h 
later (Chiron 865, Bayer, Mijdrecht, The Netherlands). Ventilator hours were 
also recorded. 
 
The type and amount of vasoactive drugs were recorded after admission to the 
PICU and 24 h later. To quantify inotropic support, inotrope scores were 
calculated as the sum of all inotrope doses correcting for potency (dopamine, 
dobutamine = 1, milrinone = 15, epinephrine = 100). Fluid intake (including 
crystalloids, colloids and blood products), output (urine, blood and serous fluid 





In a retrospective analysis of fifteen paediatric patients who had undergone 
cardiac surgery the mean (SD) cTnT concentration postoperatively was 1.92 
(2.13) ng ml-1. A power analysis based on these findings showed that we would 
need 90 patients to detect a difference in cTnT of 2 ng ml-1 with α = 0.05 and a 
power of 95%. In the same retrospective analysis the mean (SD) ventilator hours 
was 64 (37) hours and more than 50% of the patients needed two or more 
inotropic drugs postoperatively.  
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A power analysis based on these findings showed that we would need 136 
patients to detect a reduction of 18 h in ventilation time and 130 patients to 
detect a 50% reduction on inotropic support. These two variables with α = 0.05 
and a power of 80%.  
 
Data were analysed with the statistical package SPSS v10, and are summarized 
as mean and 95% confidence intervals. Patient characteristics (age, weight, 
surgery times and ventilator hours), fluid balance and blood gas variables were 
analyzed with unpaired t test for normally distributed data and Mann-Whitney 
test for non-normally distributed data. Because cTnT concentrations were not 
normally distributed, the data were first subjected to a natural logarithmic 
transformation before analysis by repeated measures ANOVA with the 
Greenhouse-Geisser correction. Categorical data were analyzed using the Chi-
squared test. Correlation coefficients between variables were calculated using 
Pearson test for normally distributed data and Spearman test for non normally 
distributed data. Values of P < 0.05 were considered statistically significant. Data 




The groups were comparable with respect to age, sex, weight, surgery times, 
aortic cross-clamp, bypass and arrest times (Table 1). The number of cyanotic 
patients and those who underwent a ventriculotomy were similar in both 
groups. There were no statistically significant differences between the groups 
with regards to ventilator hours, PaO2/FiO2 ratios, and lactate. PaO2/FiO2 ratios 
did not change significantly when values from acyanotic and cyanotic patients 
were analyzed separately.  Fluid intake did not differ between the groups 
throughout the study period, although the positive balance in the patients 
receiving dexamethasone was significantly less during the first postoperative 
day. During day two there were no differences between the two groups in terms 
of fluid intake, output and total fluid balance. Table 2 shows the type of 
operations performed in each group. Table 3 shows the type of operations 
performed in neonates while table 4 shows the type of operations performed in 
cyanotic patients. In the 10 patients from whom blood samples were obtained 
preoperatively, cTnT concentrations were less than 0.02 ng ml-1. 
 
Differences between the two groups were statistically significant (p < 0.035). 
Both groups had comparable cTnT concentrations on PICU admission (T0); 2 
(1.56 – 2.51) ng ml-1 in the group without dexamethasone and 1.8 (1.54 – 2.14) 
ng ml-1 in the group given dexamethasone.  
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    No dexamethasone  Dexamethasone 
 
Number of patients  70    70 
Age (months)   12.8 (6.4 – 19.3)  12.2 (6.7 – 17.8)     
Sex (M/F)    33/37    43/27  
Weight (kg)    7.3 (5.6 – 8.9)  6.4 (5.3 – 7.5)     
Surgery time (min)   198 (184 – 212)  207 (188 – 226) 
Bypass time (min)        124 (110 – 137)  127 (112 – 142) 
Aortic clamp time (min)  78 (64 – 91)   72 (60 – 84) 
Arrest time (min)   7.5 (2.1 – 12.8)  6.5 (2.7 – 10.3) 
Ventriculotomy (Y/N)  20/50    16/54 
Cyanotic (Y/N)   35/35    40/30 
Ventilator hours        97 (74 – 119)  99 (76 – 122) 
Inoscore day one   10 (8 – 13)   9 (6 – 12) 
Inoscore day two   11 (8 – 14)   10 (8 – 13) 
Fluid balance day one 
Intake (ml kg-1)   69 (62 – 77)   62 (55 – 69) 
Output (ml kg-1)   34 (28 – 40)   37 (32 – 42) 
Balance (ml kg-1)   35 (28 – 43)   25 (17 – 32)* 
Fluid balance day two 
Intake (ml kg-1)   100 (86 – 114)  99 (88 – 110) 
Output (ml kg-1)   73 (60 – 85)   80 (60 – 100) 
Balance (ml kg-1)   27 (16 – 37)   18 (-2.5 – 39) 
Lactate day one   1.98 (1.44 – 2.53)  1.59 (1.28 – 1.91) 
Lactate day two   1.80 (1.58 – 2.02)  1.57 (1.40 – 1.74) 
PaO2/FiO2 day one  41.8 (35.8 – 47.7)  36.6 (30.4 – 42.8) 
PaO2/FiO2 day two  32.9 (27.9 – 38)  33.3 (27.8 – 38.7) 
 
Table 1: Patient characteristics. Values expressed as mean (95% Confidence Intervals).* 




However, subgroup analysis demonstrated that only at 8 h after admission, the 
cTnT concentrations were significantly higher (p < 0.005) in the non-
dexamethasone group (3.1 (2.5 – 3.7) ng ml-1) than in the dexamethasone group 
(1.9 (1.5 – 2.4) ng ml-1).  There were no significant differences in the cTnT 
concentrations between the groups at the other times. cTnT concentrations at 
T15 were 2.65 (2.12 – 3.19) ng ml-1 in the non-dexamethasone group and 1.95 
(1.46 – 2.43) ng ml-1 in the dexamethasone group.  
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 No dexamethasone Dexamethasone 
 
AS 3  1 
Atrial  septation 1   
AVSD 7  6 
Fontan 6  2 
Glenn 5  10 
Homograft 2  2 
IAA 1  1 
MAPCA 1  1 
MVA 1  2 
MVR 1   
Norwood 4  5 
PS 1  1 
Rastelli 1  1 
Switch 10  10 
TAPVC 2  3 
ToF 9  9 
Truncus 2  1 
TVA    1 
TVR 1   
VSD 12  14 
 
Total 70  70 
 
Table 2: Type of operations. Aortic stenosis (AS), Atrioventricular septal defect (AVSD), 
Interrupted aortic arch correction (IAA), Major aortopulmonary collateral arteries (MAPCA), 
Mitral valve anuloplasty (MVA), Mitral valve replacement (MVR), Pulmonary stenosis (PS), 
Total anomalous pulmonary venous connection (TAPVC), Tetralogy of Fallot 
(ToF),Tricuspid valve anuloplasty (TVA), Tricuspid valve replacement (TVR), Ventricular 
septal defect (VSD). 
 
 
At T24 were 2.27 (1.77 – 2.76) ng ml-1 in the non-dexamethasone group and 
1.81 (1.33 – 2.28) ng ml-1 in the dexamethasone group. Figure 1 is a graphical 
representation of the changes in cTnT concentrations in the two groups. Figure 
2 and 3 show changes in cTnT concentrations in cyanotic and neonatal patients 
respectively. Correlation between cTnT concentrations at T8 and ventilator 
hours was significant although weak. Correlation coefficient was r = 0.40 in 




 No dexamethasone Dexamethasone 
 
Homograft     1 
IAA  1   1 
MAPCA 1   
MVR  1   
Norwood 4   5 
Switch  8   8 
TAPVC  1   1 
Truncus  1   1 
VSD  2   1 
 
Total  19  18 
 
Table 3: Type of operation in neonatal patients. Interrupted aortic arch correction (IAA), 
Major aortopulmonary collateral arteries (MAPCA), Mitral valve replacement (MVR), Total 
anomalous pulmonary venous connection (TAPVC). 
 
 
     
  No dexamethasone Dexamethasone 
 
Fontan  6   2 
Glenn  5   10 
Homograft     1 
MAPCA 1   1 
Norwood 4   5 
Rastelli  1   1 
Switch  10  10 
TAPVC      2 
ToF  8   7 
TVA      1 
 
Total  35  40 
 
Table 4: Type of operation in cyanotic patients. Major aortopulmonary collateral arteries 
(MAPCA). Total anomalous pulmonary venous connection (TAPVC). Tetralogy of Fallot 























Fig 1: Changes in cTnT concentrations during the first 24 h after operation. (■) T0, (●) T8, 
(▲) T15 and (▼) T24.Values expressed as mean (95% Confidence Intervals). * Denotes 



























Fig 2: Changes in cTnT concentrations during the first 24 h after operation in cyanotic 





























Fig 3: Changes in cTnT concentrations during the first 24 h after operation in neonatal 
patients. (■) T0, (●) T8, (▲) T15 and (▼) T24. Differences are not significant. 
 
When both groups were analyzed together the correlation coefficient was r = 
0.45. Correlations between cTnT concentrations (T8) and inotropic scores at 
admission and 24 h later were also weak in both groups; no dexamethasone 
group r = 0.38 (admission inotropic scores) and r = 0.51 (inotropic scores 24 h). 
In the dexamethasone group correlations were r = 0.29 (admission inotropic 




The systemic inflammatory response syndrome following CPB has been 
implicated in myocardial injury leading to low cardiac output and increased 
inotropic requirements in the postoperative period.16 One of the strategies 
aimed at protecting the myocardium is the use of steroids before CPB starts. We 
have shown in the present study that while dexamethasone reduces the 
postoperative production of cTnT in paediatric cardiac surgery, its effects are 
short lived. Fifteen hours after the end of the surgical procedure, there are no 




The concentrations of cTnT found in our study are in line with what it has been 
reported in other studies. Immer and colleagues12,17 reported mean cTnT 
concentrations of 4.06 ng ml-1 and 5.5 ng ml-1 in two consecutive studies with a 
patient population similar to ours. A mean concentration of 5 ng ml-1 was 
reported in neonates with transposition of the great arteries undergoing arterial 
switch operation with circulatory arrest.18 
 
Checchia and colleagues8 investigated the effect of dexamethasone (1 mg kg-1) 
on the postoperative production of cTnI in 28 paediatric patients undergoing 
cardiac surgery with CPB. They found a statistically significant reduction in 
cTnI concentrations 24 h after surgery in patients who received dexamethasone 
compared to those given a placebo. In our study we did not find any difference 
on the cTnT concentrations 24 h after the surgical procedure between the two 
groups. Other investigators have found that cTnT peaked at 4 hours after 
CPB,18 30 minutes after CPB20 and 2 hours after declamping.21 It is not clear 
why cTnT concentrations peaked 8 h after admission to the PICU in our 
patients. 
 
A beneficial effect of steroids on cTnI degradation has been demonstrated.9 
However this study was performed in animals subjected to a 2 h period of deep 
hypothermic circulatory arrest (DHCA) and methylprednisolone was given 
twice, 6 h before and immediately before CPB started.  
 
Imura and colleagues19 showed an age-dependent and hypoxia-related 
difference in myocardial injury during CPB. Other investigators20 have also 
noted that cyanotic patients have higher cTnT concentrations postoperatively 
than the acyanotic counterparts. Reperfusion injury may explain this 
phenomenon. When CPB starts cyanotic patients are suddenly exposed to 
normoxic concentrations of oxygen. According to our results, cyanotic patients 
do not shown any improvement in the postoperative production of cTnT when 
dexamethasone is used.  
 
The neonate myocardium has a distinct systemic inflammatory response to 
CPB, with higher production of proinflammatory cytokines when compared to 
older patients.3 We could not find any improvement in cTnT production in 
neonates treated with dexamethasone. Bronicki and colleagues7 found a 
significant reduction on postoperative fluid requirements in the paediatric 
cardiac surgical patients (n = 15) who received dexamethasone compared to the 
placebo group (n = 14). The timing and amount of dexamethasone was similar 
to our study design.  
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Fluid balance in the first postoperative day is significantly less in the 
dexamethasone group. However we consider this difference not clinically 
relevant. Fluid balance in the dexamethasone group on day one and the no 
dexamethasone group on day two are similar.  
 
The use of steroids in adult cardiac surgery remains controversial.5 To our 
knowledge there are no prospective or retrospective cohort studies that clearly 
show the influence of steroids on the clinical postoperative course. Nevertheless 
the use of steroids in paediatric cardiac surgery has become accepted practice 
in many institutions. Lindberg and colleagues22 consider that omitting the use of 
dexamethasone in children weighing less than 10 kg scheduled for cardiac 
surgery is unethical.  
 
Dexamethasone reduces C-reactive protein production without any effect on the 
release of protein S100B and Von Willebrand factor.22 The concentration of 
proinflammatory cytokines decreases when steroids are used before CPB 
starts.7,24 The reduction is even more pronounced if steroids are given before 
and during CPB.23 Oxygen delivery and cardiac output improve faster when 
steroids were used in an animal model.25 Steroids may not exert their effects 
through anti-inflammatory properties but by up-regulation of calpastatin,9 a 
protein that prevents the degradation of cTnI at the intracellular level. Even the 
timing of steroid administration seems to be relevant.26  
 
However when clinical end points have been used to test the benefits of steroids 
the results are not so impressive.27 Our study was powered to detect a 50% 
reduction on inotropic support or an 18 h reduction in ventilator hours. For 
these targets we had to include 68 patients in each group. Our results however 
show that the use of dexamethasone was not associated with any significant 
improvement in the postoperative use of inotropic drugs, fluid requirements, 
lactate production, ventilator hours or PaO2/FiO2 ratios. Some concerns have 
been raised regarding the use of cTnT in patients with chronic renal failure.28 
None of the patients included in the study had either acute or chronic renal 
failure during the study period. Some studies have suggested that cTnT 
concentrations may be used as prognostic indicators of postoperative 
recovery.17,18 In our study ventilator hours and inotropic scores correlated with 
cTnT production. However, although statistically significant the correlations 




The present study has a number of limitations. We did not investigate cardiac 
function parameters (shortening fraction, ejection fraction) and its relationship 
with cTnT elevations in the postoperative period. Atriotomy29 and 
ventriculotomy30 influence cTnI production independent of myocardial damage 
related to other factors. The number of patients undergoing atriotomy was 
similar in both groups (p < 1) and therefore unlikely to influence the results.  
More patients required a ventriculotomy in the control group (n = 20) than in 
the dexamethasone group (n = 16). While the difference is not significant (p < 
0.56) it could have affected the results.  
 
Ventilator hours in our study appear unacceptably high at first glance. 
However, some of the patients included in this study are known to have 
prolonged postoperative course (i.e. HLHS, TAPVC, Truncus arteriousus, etc.) 
while in the majority of patients (i.e. VSD, AVSD, ToF, TGA, valve surgery, 
Glenn, Fontan, etc.) extubation within 24 to 48 h is standard of care. The use of 
the mean as statistical instrument to describe the population may have 
interfered with these results. Power analysis for ventilator hours and inotropic 
support were based on average retrospective values from our intensive care 
unit.  
 
In conclusion, this study has demonstrated that in paediatric patients 
undergoing cardiac surgery the use of dexamethasone given before CPB starts 
is associated with a significant albeit short lived reduction in postoperative 
production of cTnT. Subgroup analysis showed that dexamethasone did not 
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Cardiopulmonary bypass (CPB) induces a systemic inflammatory response 
syndrome (SIRS) in patients following cardiac surgery that can lead to major 
organ injury and postoperative morbidity. Initiation of CPB sets in motion an 
extremely complex and multifaceted response involving complement activation 
along with activation of platelets, neutrophils, monocytes, and macrophages. 
This in turn initiates the coagulation, fibrinolytic, and kallikrein cascades, 
increasing blood concentrations of various endotoxins and cytokines and 
increasing endothelial cell permeability.  
 
The basic physiological insults caused by CPB have been associated with major 
postoperative morbidity, including neurological, pulmonary adrenal 
dysfunction, and/or haematological abnormalities. Additional clinical 
manifestations associated with the SIRS include increased metabolism (fever), 
fluid retention, myocardial oedema, and detrimental haemodynamic alterations. 
 
The use of steroids to minimize or prevent the consequences of SIRS in the 
postoperative period has been extensively investigated in adults. Clinical 
investigations in the paediatric population are scarce. Our aim was to investigate 
how dexamethasone could influence the associated side effects of CPB in two 
organs, the small intestine and the heart. To that effect we chose two surrogate 
markers, gut permeability and cardiac troponin T production.  
 
Intestinal mucosal ischaemia, although transient, can occur in infants and 
children during and after CPB. Gut permeability had not been previously 
investigated in children undergoing cardiac surgery. In chapter two we 
describe, in an observational study, the natural course of gut permeability in 
patients undergoing cardiac surgery with and without CPB. Gut permeability 
has been investigated in healthy children and neonates not undergoing surgical 
or medical interventions during the study period. Patients with congenital 
cardiac diseases have preoperative gut permeability values up to seven times 
what we could expect in healthy children of similar age.  
 
In patients operated without CPB gut permeability was reduced in the 
postoperative period returning to near normal values 24 hours after surgery. On 
the other hand, in patients undergoing surgery with CPB gut permeability 
deteriorated even further in the postoperative period. 
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In chapter three we report the results of a study designed to test the hypothesis 
that dexamethasone has beneficial effects on intestinal permeability during the 
postoperative period. Dexamethasone given before CPB starts reduced 
intestinal permeability within 24 h after surgery. The differences are highly 
significant when compared to control patients not given dexamethasone. In the 
investigation reported in chapter four we studied the changes in intestinal 
permeability in patients undergoing stage I of the Norwood procedure.  
 
Neonates with hypoplastic left heart syndrome (HLHS) undergo surgical repair 
in three stages. These patients suffer from an imbalanced circulation potentially 
exposing the intestine to chronic ischaemia. The surgical repair requires a 
period of circulatory arrest. It comes as no surprise, therefore, that HLHS 
patients are at high risk of developing necrotizing enterocolitis in the 
postoperative period, with devastating consequences. We found that HLHS 
patients have abnormal intestinal permeability before and after surgery.  
 
Rhamnose is one of the four sugars used to test intestinal permeability. For the 
last thirty years it has been assumed that rhamnose is an inert sugar not 
metabolized by the human body. We have found this not to be the case, and 
the results are presented in chapter five.      
 
The type of anaesthetic agent used during adult coronary bypass surgery may 
influence considerably the postoperative production of cardiac troponin T 
(cTnT), a protein that reflects the extent of myocardial damage after a period of 
hypoxia. In particular halogenated ethers may exert its effect through a process 
called anaesthetic preconditioning, a phenomenon similar to ischaemic 
preconditioning.  
 
Anaesthetic preconditioning has not been investigated in paediatric cardiac 
surgery to the same extent as in adult cardiac surgery. In chapter six we present 
a study of the effects of three different anaesthetic agents, propofol, midazolam 
and sevoflurane, on the postoperative production of cTnT in paediatric cardiac 
surgical patients. Contrary to what happens in adult patients we could not find 
significant differences in the postoperative production of cTnT when 
midazolam, propofol or sevoflurane were used as anaesthetic agents. 
 
In chapter seven, we report on a study designed to test the hypothesis that 
dexamethasone given before CPB starts may have myocardial protective effects 
as assessed by the postoperative production of cTnT. Subgroup analysis in 
cyanotic and neonatal patients was also evaluated for the same hypothesis.  
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We found that dexamethasone did reduce postoperative cTnT concentrations. 
However, the reduction was short lived and was not accompanied by 


































































































































I am grateful to my colleagues in the anaesthetic department, the paediatric 
intensive care unit and the paediatric cardiac surgery department for their 
cooperation. Without their help this thesis would never had come to fruition. A 
special thanks to the nursing staff in the paediatric intensive care unit and the 






























































Ignacio Malagon was born in Madrid, Spain on 3 December 1962. He attended 
medical school at the Universidad Complutense Madrid and graduated in 1986. 
In 1988 he obtained a Master in Philosophy on biochemistry at the same 
university. His anaesthetic training started in 1990 in Great Britain, and included 
a senior house officer rotation at Leicester Royal Infirmary and registrar 
positions in Birmingham and St BartholomewÊs Hospital in London. In 
December 1994 he successfully completed the final exam for the fellowship at 
the Royal College of Anaesthetists of United Kingdom (FRCA). The 
subsequent training included a post as fellow in adult intensive care at St 
GeorgeÊs Hospital in London and a senior registrar rotation at GuyÊs and St. 
ThomasÊ Hospital in London. To round up his training he completed a year 
paediatric intensive care fellowship program at the Vancouver ChildrenÊs 
Hospital in British Columbia, Canada. 
 
In 1999 he was appointed consultant cardiac anaesthetist with a special interest 
in paediatric cardiac surgery at the Leiden University Medical Centre, where he 

























LIST OF PUBLICATIONS 
 
Malagon Calle JI, Ramos Atance JA. Participacion del sistema inmune en la 
etiopatogenia de la enfermedad periodontal. Avances en Periodoncia 
1990;2:165-175. (Role of the immune system in the aetiology of the periodontal 
disease). 
 
Malagon Calle JI, Ramos Atance JA. Papel de las bacterias en la etiopatogenia 
de la enfermedad periodontal. Avances en Periodoncia 1990;2:177-187. (Role of 
local microorganisms in the aetiology of periodontal disease). 
 
Malagon I. Use of ketorolac and fentanyl during outpatient gynaecologic 
surgery: A statistical analysis. Anesthesia & Analgesia 1994;79:392 
 
Malagon I. Nimodipine and regional blood flow: Statistical analysis. Anesthesia 
& Analgesia 1994;79:817-818. 
 
Malagon I. Statistical analyses. Critical Care Medicine 1995;23:599-600. 
 
Malagon I. Comparison of sevoflurane with halothane: Statistically valid? British 
Journal of Anaesthesia 1995;74:724. 
 
Lamb FJ, Malagon I. Comparison between two methods of measuring the 
cardiac output: misleading analyses? British Journal of Anaesthesia 1995;75:821. 
 
Malagon I. The use of t-test with non parametric data: Fentanyl withdrawal 
syndrome. Critical Care Medicine 1995;23:2058-2059. 
 
Malagon I, Grounds RM, Bennett ED. Changes in cardiac output during air 
ambulance repatriation. Intensive Care Medicine 1996;22:1396-1399. 
 
Malagon I, Lamb FJ. Comparing two methods of clinical measurement: Bland 
and Altman, a review of the anaesthesia and critical care literature. Clinical 
Intensive Care 1996;7:308-310. 
 
Malagon I, Karalliede L, Adams AP. Non invasive cardiac output measurement 




Malagon I, Lamb FJ. Two methods of measuring oxygen saturation: Why the 
Bland and Altman statistical technique is necessary? Anaesthesia and Intensive 
Care 1996;24:123-125. 
 
Malagon I. Changes in systemic vascular resistance during exposure to 
moderate altitude. American Journal of Obstetrics and Gynecology 
1996;175:505. 
 
Malagon I. The use of standard error of the mean instead of standard deviation. 
Does it matter? Anaesthesia 1996;51:609. 
 
Malagon I. Drugs interacting with the thyroid function. In: Karalliede L, Henry 
J, eds. Handbook of drug interactions. (1997) Edward Arnold. 
 
Wensley D, Malagon I. Continuous versus intermittent furosemide infusion in 
critically ill infants after open heart operations (Discussion forum). Annals of 
Thoracic Surgery 1997;64:1133-1139 (http://www.sts.org/annals). 
 
Malagon I. Hydroxyl radical generation in oxygen-treated infants. Pediatrics 
1998;102:437. 
 
Rhodes A, Lamb FJ, Malagon I, Newman PJ, Grounds RM, Bennett ED. A 
prospective study of the dobutamine test in patients with sepsis, severe sepsis or 
septic shock. Critical Care Medicine 1999;27:2361-2366. 
 
Seear M, Malagon I, Hui H, Alexander J, Daoust C, Skippen P. Validation of a 
mathematical model to predict intrapulmonary shunt non-invasively. Canadian 
Journal of Anaesthesia 1999:46;483-487. 
 
I Malagon, W Onkenhout, G Klok, PFH van der Poel, JG Bovill, MG 
Hazekamp. Gut permeability in paediatric cardiac surgery. British Journal of 
Anaesthesia 2005;94:181-185 
 
I Malagon, K Hogenbirk, J van Pelt, MG Hazekamp, JG Bovill. Effect of three 
different anaesthetic agents on the postoperative production of cardiac troponin 
T in paediatric cardiac surgery. British Journal of Anaesthesia 2005;94:805-809 
 
I Malagon, W Onkenhout, L Linthorst, G Klok, PFH van der Poel, JG Bovill, 
MG Hazekamp. Dexamethasone reduces gut permeability in paediatric cardiac 
surgery.  Journal of Thoracic and Cardiovascular Surgery 2005; (in press) 
 108
I Malagon, W Onkenhout, G Klok, PFH van der Poel, JG Bovill, MG 
Hazekamp. Gut permeability in neonates following a stage I Norwood 




Malagon I. Haemodynamic effects of air travel. British Journal of Anaesthesia 
1996;76:4:590P. 
 
Malagon I, Lamb FJ. The use of Bland and Altman statistical method in the 
anaesthesia literature. British Journal of Anaesthesia 1996;77:2:285P. 
 
Malagon I, Burke S, Grounds RM. pHi changes during elective small and large 
bowel surgery. Intensive Care Medicine 1996;22: (Supplement 3) S433. 
 
Malagon I, Lamb FJ. Comparing two methods of clinical measurement: the use 
of Bland and Altman statistical method in the critical care literature. Intensive 
Care Medicine 1996;22: (Supplement 3) S298. 
 
Rhodes A, Malagon I, Lamb FJ, Newman PJ, Grounds RM, Bennett ED. 
Failure to increase oxygen consumption is a predictor of mortality in septic 
patients. Intensive Care Medicine 1996;22: (Supplement 3) S274. 
 
Malagon I, Alexander J, Hui H, Daoust C, Skippen P, Seear M. Validation of a 
mathematical model to predict intrapulmonary shunt. Intensive Care Medicine 
1998;24: 
 
Malagon I, Alexander J, Hui H, Daoust C, Skippen P, Seear M. Correlation 
between cardiac output and mixed venous oxygen saturation during partial 
liquid ventilation. Intensive Care Medicine 1998;24 
 
van der Wal ME, Malagon JI, Onkenhout W, Bovill JG, Hazekamp MG. Het 
effect van een cardiopulmonale bypass op de darmpermeabiliteit in een 
pediatrische populatie na palliative of corrective hartchirugie. Ned Tijdschr 
Geneeskd 2003;147(22):1093-1094. 
 
I Malagon, K Hogenbirk, MG Hazekamp, JG Bovill. Effect of dexamethasone 
on postoperative cardiac troponin T production in paediatric cardiac surgery. 
European Journal of Anaesthesiology 2005;22: (Supplement 35) O48. 
 
 109
I Malagon, W Onkenhout, L Linthorst, G Klok, PFH van der Poel, JG Bovill, 
MG Hazekamp. Dexamethasone improves gut permeability in paediatric 
cardiac surgery. European Journal of Anaesthesiology 2005;22: (Supplement 35) 
O59. 
 
I Malagon, W Onkenhout, G Klok, PFH van der Poel, JG Bovill, MG 
Hazekamp. Gut permeability in neonates following a stage I Norwood 
procedure. European Journal of Anaesthesiology 2005;22: (Supplement 35) 
O60. 
 
